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ABSTRACT 
 
 
A-kinase anchoring proteins (AKAPs) are signaling scaffolds which provide 
spatial and temporal organization of signaling pathways in discrete subcellular 
compartments. Through tethering the cyclic-AMP dependent protein kinase A (PKA), 
AKAPs target PKA activity to distinct regions in the cell, bringing PKA in close 
proximity to its target proteins. This provides a high level of specificity and regulation 
of PKA and its role in mediating a number of biological processes, one of which is cell 
migration. Cell migration is a highly dynamic and fundamental process, when 
misregulated can lead to a number of pathologies. The process of cell migration 
requires integration and coordination of actin cytoskeletal dynamics, adhesion turnover, 
and contractility. The important role of PKA in regulating the cellular processes 
involved in cell migration has been extensively studied. Our lab has shown that PKA 
activity and spatial distribution through AKAPs are localized to the leading edge of 
migrating cells and are required for effective cell migration, yet the specific AKAPs 
responsible remain unknown.  
Traditional methods for identifying AKAPs suffer from a number of limitations. 
Therefore the objective of the enclosed work is to establish and characterize a novel 
approach for the identification of cytoskeletal and adhesion-associated AKAPs. We 
show for the first time, an in vitro approach to identify cytoskeletal AKAPs which may 
be responsible for localizing PKA to the leading edge of migrating cells.  
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CHAPTER 1: Literature Review 
1.1 Cell Migration 
 
1.1.1 Introduction to Cell Migration 
Cell migration is a fundamental process involved in many essential biological 
processes such as wound healing, embryogenesis, and the immune response.  When left 
unregulated, aberrant cell migration can lead to autoimmune diseases and cancer cell 
metastasis (Vincente-Manzanares and Horowitz, 2011). Cell migration is a highly 
dynamic process, which involves the interplay between tension sensing, contractility, 
cytoskeletal dynamics, and adhesion turnover, all converging on directional cell 
movement. The involvement of cell migration in a number of fundamental biological 
processes underscores its importance and the need for tight spatiotemporal coordination 
and integration of many proteins and signaling pathways. While the field has 
significantly advanced our working knowledge of cell migration over the past few 
decades, furthering our understanding of the mechanisms underlying cell migration is 
critical.  
1.1.2 Basic Mechanisms of Cell Migration 
Currently, cell migration is viewed as a cyclical process (Ridley et al., 2003) 
and involves four steps: protrusion, adhesion to extracellular matrix, retraction, and 
translocation (Howe, 2004). Directional cell migration is initiated by an extracellular 
signal, which results in a dynamic reorganization of the actin cytoskeleton leading to 
protrusion of the cell (Parsons et al., 2010). These protrusive structures can be broad 
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and large lamellipodia, characterized by the branching of actin filaments, or are long, 
thin cables called filopodia. Protrusions make contact with the extracellular matrix, 
forming focal adhesions, stabilizing the protrusive structures (Zamir, 2001; Geiger 
2011). Cell migration continues through the utilization of the contractile machinery, 
which among other things promotes disassembly of focal adhesions at the trailing edge 
of the cell, promoting directional migration (Figure 1) (Vincente-Manzanares et al., 
2007).   
 
 
                   Figure 1: Structural elements of a migrating cell 
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Directional cell migration requires cellular polarity, which means the molecular 
mechanisms at the leading edge (the front) and the trailing edge (the back) of the cell 
are different. Establishing and maintaining cell polarity is mediated by the integration 
of many proteins including Rho family GTPases, phosphoinositide 3-kinases (PI3Ks), 
actin polymerization, integrins, actin, microtubules, myosin II, and cAMP-dependent 
protein kinase A. While the molecular mechanisms that govern cell migration are 
generally consistent between cell types, the relative contributions of signals depend on 
the specific stimulus and cell type.  
Cell migration is largely driven by changes in the cytoskeleton and interactions 
with the extracellular matrix (ECM) through complexes of structural and signaling 
proteins referred to as focal adhesions. This dynamic process is tightly regulated 
through a number of biochemical and mechanical signaling pathways.   
 
1.1.3 The Cytoskeleton 
The cytoskeleton is the cellular architecture and is responsible for establishing 
cell shape, providing mechanical strength, and cell motility. It is made up of  three 
molecules, actin, microtubules, and intermediate filaments. While the role of actin and 
microtubules in cell migration has been well established, the contributions from 
intermediate filaments have not been defined. 
1.1.3.1 Actin and Actin Dynamics 
 
Actin filaments are comprised of monomeric globular, G-actin subunits which 
bind to one another through a process driven by ATP hydrolysis (Vincente-Manzanares 
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and Horowitz, 2011). Actin polymerization is the process by which ATP bound G-actin 
is hydrolyzed to ADP+Pi and a bond is formed between actin subunits. The ADP+Pi 
stabilize the subunits creating filamentous actin, F-actin, the stable filaments 
responsible for the cellular integrity. Actin filaments are polarized structures, 
displaying a fast “barbed” end, the site of new subunit incorporation, and a “pointed” 
end, the origin of the growing filament (Korn et al., 1987; Carlier et al., 2003). There 
are a number of different types of actin filaments, whose formation is regulated through 
the number of actin filaments and the available accessory proteins. The different 
morphologies give rise to different structures at distinct subcellular locations and can be 
characterized as lamellipodia, filopodia, or stress fibers (Mattila et al., 2008; Mejillano 
et al., 2004).  
In lamellipodia, actin is arranged in large, broad, branched structures, the 
assembly of which is catalyzed by the ARP2/3 complex (Pollard and Borisy 2003; 
Mitchison and Cramer 1996). This complex binds to the sides of the growing actin 
filament, promoting the formation of a new filament, creating a branched network of 
actin filaments. Lamellipodia are followed closely with the lamellum, where the actin is 
more closely bundled (Ponti et al., 2004 ). This comprises the protrusions at the leading 
edge of cell, which in combination with contractile forces push the membrane forward 
resulting in directional migration.  
In contrast, filopodia, are long, thin cable-like protrusions which initiate from 
the plasma membrane. They have been described as ‘antennae’ that cells use to probe 
their local environment (Mattila et al., 2008). Protrusion of filopodia is thought to occur 
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through filament tread milling, which involves attachment of actin subunits and 
elongation at the barbed end, while releasing actin from the pointed end (Glenney et al., 
1981).   
1.1.3.2 Actin Binding Partners 
 
Building different morphologies of actin filaments, requires an extensive 
network of accessory proteins. These are intimately involved in not only the regulation 
of actin cytoskeletal dynamics, but are critical in tension sensing, mechanotransduction, 
and signal transduction. There are over 100 known actin binding partners, and while the 
purpose of this review is not to talk in detail about them, a few are of particular note. 
As mentioned before, the Arp2/3 complex is responsible for actin polymerization in the 
lamellipodia (Pollard and Cooper 2009). Activation of the Arp2/3 complex is localized 
by the Wiskott-Aldrich syndrome protein (WASP/WAVE) family members (Pollard 
and Borisy, 2003). Profilin binds actin monomers and prevents self-nucleation, while 
helping target the monomers to the barbed end of the growing filament (Ridley et al., 
2003). The elongation of actin filaments is regulated by capping proteins such as 
cofilin, which also aid in severing filaments and promoting actin dissociation (Ridley et 
al., 2003). There are a number of proteins, which help to crosslink and stabilize the 
actin network such as cortactin, filamin A, and α-actinin (Pollard and Cooper 2009). 
Filopodial structures have additional proteins, which are enriched such as the 
Ena/VASP proteins, which antagonize capping and branching and thus promote 
continuous elongation of filaments. Additionally, fascin helps to bundle actin filaments 
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and is thought to help generate the stiffness needed to propel the plasma membrane 
forward in filopodial-mediated protrusion (Pollard and Cooper 2009).  
 
1.1.3.3. Rho Family GTPases 
 
Rho family small guanosine triphosphate (GTP)-binding proteins (GTPases) 
comprise a family of molecular switches, which control many signaling pathways 
required for a number of cellular processes. GTPases are relatively small enzymes 
whose primary role is to hydrolyze the gamma phosphate from guanine-5-triphosphate 
(GTP) and are conformationally regulated by the binding of GTP and GDP. In their 
inactive form, they are bound to GDP, and are activated once GDP is exchanged with 
GTP. GTPase activity is mediated through a balance between guanine nucleotide 
exchange factors (GEFs) and GTPase-activating proteins (GAPs) and is tightly 
regulated. GTPases have been implicated in a number of aspects of cell migration, 
including the control and formation of leading edge actin structures such as filopodia 
and lamellipodia, and in the coordination of adhesion structures.   
The first report of Rho family GTPases regulating cell migration came in 1995, 
when Rho, Rac, and Cdc42 were identified (Nobes and Hall 1995). While all part of the 
same superfamily, Rho, Rac, and Cdc42 all have slightly different roles with respect to 
their regulation of cell migration. Rho primarily controls contractility-dependent 
processes including the formation or stress fibers (Brahmbhatt and Klemke 2003).  
Both Rac and Cdc42 mediate actin polymerization through their interactions 
with WASP/WAVE family of Arp2/3 complex activators (Ridley and Cooper 2009). 
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Rac drives lamellipodial protrusion formation through activation of WAVE/Scar 
protein through biding of an intermediate protein, IRSp53 (Cory and Ridley 2002). This 
in turn regulates the activity of the Arp2/3 complex, controlling the formation of actin 
structures at the leading edge. It has been shown that Rac activation is localized to the 
leading edge of protruding and migrating cells (Aoki et al., 2004; Kraynov et al., 2000). 
Additionally, Rac affects the migratory machinery through its activation of several 
effector proteins such as PAKs, MLCK, RLC, LIMK, and stathmin (Vincente-
Manzanares et al., 2007).  
Cdc42 is the primary regulator among the Rho GTPases of cell polarity and is 
active towards the front of migrating cells (Itoh et al., 2002). Cdc42 binds WASP 
proteins, which stimulates Arp2/3 complex to induce branched actin polymerization. 
Cdc42 also exerts its effects on cell polarity through organization and localization of 
the microtubule-organizing center (MTOC) (Rodriguez et al., 2003). One downstream 
target of Cdc42 is PAK1, which itself can regulate Cdc42, creating a positive feedback 
loop (Ridley et al., 2003).   
1.1.3.4 Myosin II 
 
Myosins are a class of actin-binding molecules, which are often referred to as 
motor proteins (Aguilar-Cuenca et al., 2014). The globular head of the myosin binds 
actin and also has ATPase activity, which causes conformational movements which 
allows the myosin to slide along the actin filament, generating contractile forces 
(Warrick and Spudich, 1987). The affinity for actin changes, depending on the stage in 
ATP hydrolysis (Clarke and Spudich, 1977). The role of non-muscle myosin II (NMII) 
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has been well characterized as playing a central role in the cellular response to 
mechanical cues, because of its inherent ability to generate mechanical forces (Aguilar-
Cuenca et al., 2014). Myosin II also cross-links the actin cytoskeletal and facilitates 
reorganization of lamellar actin through its interactions with formin and alpha-actinin 
(Choi et al., 2008). Myosin II motors have been shown to regulate focal adhesion 
morphology during the maturation process (Stricker et al., 2013).  Myosin II activity is 
controlled by phosphorylation at several sites, the most important being Ser19 (Ikebe, 
2008). A number of kinases known for their involved in migration and adhesion 
dynamics have been shown to be responsible for this phosphorylation. Additionally, 
cAMP-protein kinase A, Rho-associated kinase (ROCK) and integrins have been shown 
to regulate the activity of myosin II.  
 
1.1.4 Cell Adhesion  
Cellular migration requires stabilization of leading edge protrusions via 
interactions with their extracellular matrix. Cell-matrix adhesions are not simply static 
structure, but are highly dynamic and are under tight spatial and temporal control. 
Through this tight regulation, signaling proteins dictate the location, duration, and type 
of cell-matrix adhesion. Cell-matrix adhesions connect the cytoskeleton through the 
cytoplasmic domains of adhesions receptors, creating contact with the extracellular 
matrix, and allowing cells to create a stable and force-generating contact point. By 
using myosin II-mediated contractile forces, cells are able to translate the mechanical 
forces felt at adhesion sites into intracellular biochemical signals. This translational 
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process called mechanosensing (Schiller and Fassler, 2013). The mechanical tension at 
sites of adhesions, is responsible for promoting the maturation of adhesions (Balaban et 
al., 2001). 
 
1.1.5 Importance of Cellular Adhesion 
The deregulation of adhesion assembly and disassembly is common to many 
diseases. Of particular note is cancer, where the regulation of cell adhesion is critical to 
a cell’s ability to successfully detach and invade distal sites of metastasis. The ability of 
a cell to sense and respond to its local environment, migrate, and invade distal sites are 
dependent on the proper regulation of adhesion. Large scale genetic and proteomic 
studies have shown many adhesion proteins to be abnormally regulated during tumor 
progression (Hoffman et al., 2011).   
 
 1.1.6 Structure of Adhesions 
Cell matrix adhesions were first described over 40 years ago (Curtis, 1964) 
however it took a number of years to elucidate their structure and function. Over the 
past few years, progress has been made in our understanding of the proteins involved at 
sites of cell-matrix adhesions, as well as the types of adhesive structures. More 
recently, focal adhesions have been isolated and shot-gun proteomics has been used to 
identify the constituents (Kuo et al., 2012; Zaidel-Bar and Geiger 2010; Schiller et al., 
2011). Within the past four years, three-dimensional super-resolution fluorescence 
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microscopy has been used to understand the architecture of focal adhesions 
(Kanchanawong et al., 2010).   
There are four classic types of adhesive structures, which can exists in a single 
cell at any one time; nascent adhesions, focal complexes, focal adhesions, and fibrillar 
adhesions (Puklin-Faucher and Sheetz, 2009; Zaidel-Bar and Geiger, 2010). The 
components of adhesions has been characterized over the past few years, and over 200 
different molecules have been found to associate with adhesions (Zaidel-Bar et al., 
2007) and proteins from a variety of families have been identified including 
cytoskeletal proteins, transmembrane receptors, and signal transduction molecules. The 
critical role adhesions play in diverse cell processes underscores their importance and 
the need for further characterization.  
 
1.1.7 Adhesion Dynamics 
Adhesion dynamics are tightly regulated and is a highly dynamic process 
involving continual assembly-disassembly.  Adhesion of a protruding cell edge begins 
with the formation of a nascent adhesions in the lemmellipodium (Parsons et al., 2010). 
These are short lived and quickly turnover into focal complexes and eventually into 
focal adhesions which reside at the ends of large actin bundles (Gardel et al., 2010).  
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1.1.8 Focal Adhesion Components 
As mentioned before, focal adhesions serve as the link between the actin 
cytoskeleton and the ECM, interpreting extracellular cues and converting them into 
intracellular signals. Their important function requires a complex array of molecules 
and recent proteomic and bioinformatics approaches have identified over 150 proteins 
associated with focal adhesions (Zaidel-Bar and Humphries 2007; Humphries et al., 
2009). Central to focal adhesions are the major transmembrane receptors, integrins. The 
host of proteins at sites of focal adhesions come from a host of different molecular 
classes including cytoskeletal proteins, kinases, modulators of small GTPases, 
phosphatases, and other enzymes (Zamir and Geiger, 2001). Many of these proteins 
directly bind to actin or the cytoplasmic tails of integrins, while others transiently 
associate with adaptor/scaffolding proteins. Because of the diversity and breadth of 
protein-protein interactions at sites of focal adhesions, they have become a site for 
organization of multi-protein signaling complexes. The list of focal adhesion proteins is 
extensive and therefore this review will discuss a selected group of proteins drawn from 
each of the major families of proteins.  
 
1.1.8.1 Scaffolding Proteins 
 
Focal adhesions contain several proteins that function as signaling scaffolds for 
the components of focal adhesions.  This provides a mechanism by which signaling 
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enzymes can associate with their substrates and leads to changes in cell morphology 
and behavior. In addition to p130Cas and Crk, paxillin is one of the best described 
scaffolding proteins at focal adhesions (Webb et al., 2004). Paxillin has a number of 
motifs that facilitate its binding to signaling proteins such as Src, FAK and PKL (Webb 
et al., 2004). It also contains C-terminal LIM domains which allows it to attach to the 
cell membrane and interact with the phosphatase PTP-PEST (Turner 2000). 
Recruitment to focal adhesion complexes is mediated by binding to the β1 and α4 
integrin cytoplasmic tails (Liu et al., 2002).  
Phosphorylation of paxillin is important for focal adhesion formation and 
maturation. For example, paxillin phosphoryatlion on Y31, Y119, or S273 results in 
robust protrusion and focal adhesion assembly in protrusions (Nayal et al., 2006, 
Zaidel-Bar et al., 2007). Additionally, in vivo data shows that the phosphorylation of 
paxillin leads to complex formation with FAK to regulate dynamics of nascent 
adhesions (Choi et al., 2011) and phosphorylation by FAK and Src lead to the creation 
of addition binding sites for adaptor proteins (Turner 2003). Paxillin has also been 
implicated to inhibit α4β1-dependent cell migration through its binding to α4 integrin 
tail (Goldfinger et al., 2003).  
Paxillin acts as a critical component of focal adhesions through its activation of 
Rho family GTPases. Both Cdc42 and Rac co-localize with paxillin and stimulate the 
activity of p21-activated kinase (PAK) (Manser et al., 1998). Activated PAK in turns 
modulates the actin cytoskeleton into lamellipodia and filopodia formation (Delorme-
Walker et al., 2011).  
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1.1.8.2 Signaling Proteins 
 
Phosphorylation is one of the key signaling events that occur at focal adhesions, 
both at tyrosine and serine/threonine sites. Tyrosine phosphorylation at focal adhesions 
has been well characterized as providing binding sites for SH2-containing proteins thus 
regulating the activation of many signaling kinases and phosphatases (Webb et al., 
2004). There are a number of tyrosine kinases such as focal-adhesion kinase (FAK), 
Src, Abl, and Csk as well as serine/threonine kinases such as PAK and PKC that are 
found in focal adhesions (Zamir and Geiger, 2001). While these all have important 
roles in regulating adhesion dynamics and cell behavior, FAK is one of the best 
characterized and therefore will be the focus of the subsequent section.  
FAK is a tyrosine kinase which localizes to focal adhesions via its C-terminal 
focal adhesion targeting domain (FAT) (Hildebrand et al., 1993). It is centrally 
positioned for regulating focal adhesion dynamics through its association with talin, 
providing the link between integrin-mediated signal transduction and subsequent 
downstream pathways (Chen et al., 1995). It phosphorylates a number of targets 
involved in adhesion dynamics (Chen et al., 1995) and therefore has evolved as one of 
the central and most important regulators of signaling complexes at focal adhesions.  
Phosphorylation at Y397 has been shown to result in the recruitment of Src-family 
PTKs, which in turn causes Src-mediated phosphorylation and thus creating further 
binding sites for proteins such as Grb2 (Schlaepfer et al., 1999).  
 14 
The requirement for FAK in cell migration has been demonstrated through 
experiments showing that fibroblasts from FAK-null mice exhibit a decreased rate of 
migration and an increase in the number of size of adhesions (Ilic et al., 1995). FAK’s 
role in adhesion turnover has been further characterized and recently it has been shown 
that FAK-Src signaling regulates adhesion disassembly through ERK and MLCK 
(Webb et al., 2004). Furthermore, FAK has been implicated in cancer cell invasion and 
studies with human tumor tissues and tumor-derived cell lines have shown FAK 
expression to be high (Cance et al., 1995). Furthermore, FAK recruitment and 
activation are associated with integrin clustering, and FAK complexes with proteins 
such as talin, have been shown to regulate focal adhesion turnover (Lawson et al., 
2014).  
FAK also plays a role in regulating adhesion dynamics through its activation of 
small GTPases by binding and phosphorylating their exchange factors (Webb et al., 
2004). Given the role of small GTPases in regulating adhesions, further highlights the 
importance of FAK in focal adhesion dynamics.  
 
1.1.8.3 Integrins 
 
Integrins are one of the major transmembrane receptors central to adhesions. 
They play a structural role linking the actin cytoskeleton to the extracellular matrix 
(ECM) and mediate all cell-ECM interactions. Integrins also serve as a major site for 
transmission of mechanical and biochemical signals from the ECM to the inside of the 
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cell. Many cellular processes rely on signal cascades organized by proteins interacting 
with the cytoplasmic tail of integrins.  
Integrins are comprised of non-covalently associated α and β-glycoprotein 
subunits, which pass the membrane through a single membrane helix (Lad et al., 2007).  
Combinations of the α and β-chains form the 24 different heterodimers, which 
contributes to the diversity of integrins and ultimately enabling cells to respond to 
different extracellular cues (Geiger and Zaidel-Bar, 2012). The integrin heterodimer is 
entirely dependent on the ECM ligand present surrounding the cell. Upon binding the 
extracellular ligand, a conformation change occurs allowing assembly of multi-protein 
complexes and thus initiating downstream signaling pathways. Because integrins 
contain no enzymatic activity, they rely on the recruitment of signaling enzymes for 
proper signal transduction.  
The cytoplasmic tail has been shown to bind to at least 12 different adaptor 
proteins including tensin, filamin A, talin, plectin, paxillin, talin, and α-actinin (Zaidel-
Bar, 2007a). Further links to the actin cytoskeleton occur through second and third tier 
scaffolds such as, paxillin-actopaxin, kindlin-1-migfilin-VASP (Zaidel-Bar, 2007a). 
Maintaining the integrin-actin connection is critical to the function of adhesions, 
specifically with respect to mechanotransduction.   
Integrin activation is the process defined by the switching of affinity for ECM, 
from that of low to that of high affinity state. In addition to the ECM itself, integrins 
can be regulated by a number of cytoplasmic proteins. The binding of talin has now 
been characterized as the final step in integrin activation (Calderwood et al., 2013) and 
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the binding of talin to integrins is a highly regulated process as well (Morse et al., 
2014). Kindlin is another protein, which plays a role in integrin activation, while 
creating additional binding sites for other proteins involved in adhesion dynamics 
(Brahme and Calderwood, 2012; Brahme et al., 2013; Tu et al., 2003). The critical role 
of integrins requires their activity to be tightly spatial and temporally controlled. In 
addition to direct integrin activators, integrins have also been shown to be negative 
regulated by proteins binding to the cytoplasmic tails (Morse et al., 2014). Filamin A, is 
a large actin-cross linking protein is one of the most well characterized integrin 
inhibitors. Through competition for binding to the integrin β-tail with talin and kindlin-
1, filamin A has been shown to suppress integrin activation (Kiema et al., 2006; Shifrin 
et al., 2009; Takala et al., 2008). Phosphorylation of filamin A has been shown to 
modulate the interaction with integrins, and thus their activity. Of particular note is 
regulation of integrin binding through phosphorylation at Ser2152 (Chen et al., 1995).  
The multi-protein signaling complexes that form around integrins are 
responsible for transmitting signals from integrins and regulating the cytoskeletal 
dynamics involved in cell migration and adhesion. As mentioned before, there are tiers 
of proteins, which help connect the actin cytoskeleton to integrin cytoplasmic tails. 
Proteins such as talin and filamin A are particular important in this connection as they 
have been shown to induce conformational changes under tension, strain, and stretching 
(Ehrlicher et al., 2011; Chen et al., 2009; Nakamura et al., 2009; Nakamura et al., 
2007). Furthermore, force applied across filamin actually causes release of the 
filaminA-associated Rho GTPase activating protein (FilGAP), which allows for another 
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level of regulation of the cytoskeleton (Ohta et al., 2006). Integrins are also able to 
affect cytoskeletal dynamics through regulation of Rho family GTPases although these 
signaling pathways are beyond the scope of this dissertation.  
 
1.1.8.4 The Integrin Adhesome 
 
Advances in technology over the past decade have allowed for the visualization 
of dynamic focal adhesion turnover and cytoskeletal dynamics. It is therefore widely 
appreciated that the proteins assembled at sites of integrins and focal adhesions are in 
constant flux. Currently, there are 156 components (Zaidel-Bar et al., 2007a,b) with an 
even larger number of direct protein-protein interactions. As the field begins to uncover 
the complexity and connectivity of the integrin adhesome, it has become clear that in 
order to provide both strong adhesions and dynamic turnover, the proteins present at 
any one time must change (Zaidel-Bar et al., 2007a). Due to the extensive network of 
protein-protein interactions, it is likely that a snap-shot of the cell at one time would 
only show proteins binding a fraction of their binding partners. This combined with 
differences in tissue and cell type expression, contribute to the diversity of signals 
which are transduced. Even more, proteins may interact with different binding partners 
within the same cell and even within the same adhesion, furthering the complexity of 
the adhesion networks that are possible.  
The complex of proteins assembled at integrins and adhesions must be tightly 
regulated in order to exert a specific function. Regulation can occur through protein 
conformation, changes in temperature, pH or ion concentration, binding of proteins, or 
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post-translational modifications (Zaidel-Bar et al., 2007a). It is also likely that force 
acts to play a role in altering the profile of proteins involved in the integrin adhesome 
by causing conformational rearrangements in molecules exposing and hiding discrete 
binding sites. This has been shown recently in single-molecule stretch experiments of 
both talin and filamin A, known integrin binding partners (del Rio et al., 2009; Chen et 
al 2009).   
As the extensive network of proteins, which make up the integrin adhesome 
unfolds, the mechanisms and regulation of these complexes become impossible to 
follow.  What is clear however, is their importance in regulating important cellular 
processes including cell migration through numerous signaling pathways. One 
signaling pathway of particular importance is the cAMP dependent protein kinase A 
pathway, which the remainder of this work will focus on.  
Signaling events are regulated through a variety of mechanisms but one of the 
most widely used is phosphorylation. Phosphorylation is the process in which a gamma 
phosphate is transferred from adenosine-triphosphate to its substrates in a mechanism 
called phosphorylation. Protein phosphorylation is a covalent, yet reversible, 
modification of proteins, which regulates many cellular functions. Almost every 
signaling pathway includes protein kinases and in commonly, protein phosphatases, 
which act to remove the phosphate group. Phosphorylation has diverse roles, and the 
presence of a phosphate group can affect enzymatic activity of proteins, induce 
conformational changes, target proteins for degradation, create docking sites for 
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subsequent proteins to bind, and mediate protein-protein interactions. Phosphorylation 
is one of the most widely used regulatory mechanisms in eukaryotic organisms.     
 
 
1.2 cAMP/PKA Signaling 
 
 
1.2.1 Structure and Function of PKA 
The cAMP-dependent protein Kinase-A (PKA) is one of the most well 
characterized signaling enzymes in the cell, and whose role has been implicated in a 
number of cellular processes. In its inactive form, PKA is a heterotetrameric enzyme 
comprised of two regulatory (R) and two catalytic (C) subunits. There are two types of 
PKA holoenzyme, defined either as RI or RII. There are four types of R subunits, 
encoded by four genes (RIα, RIβ, RIIα, RIIβ) and only three genes encoding the C 
subunits (α, β,	   and	   γ). The regulatory subunits function to maintain holoenzyme 
integrity, facilitate N-terminal dimerization, provide a mechanism for A-kinase 
anchoring, and release the catalytic subunits upon binding of cAMP (Howe, 2004). 
Upon binding two molecules of cAMP to the regulatory subunits, a conformational 
change occurs releasing the catalytic subunits, which are then free to phosphorylate a 
number of downstream substrates.  
PKA is a serine threonine kinase, which phosphorylates proteins at a conserved 
consensus site, RXXS/T (where X is any amino acid). PKA has a diversity of 
substrates, drawn from many functional classes including nuclear proteins, cytoplasmic, 
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mitochondrial, and cytoskeletal. Regulation of PKA is a well characterized mechanism 
through which activation of G-protein coupled receptors are coupled to the G-protein, 
Gαs, which activates downstream effectors such as adenylate cyclase to convert ATP to 
cAMP (Ross et al., 1977). PKA’s activity is dependent on the local concentrations of 
cAMP. As a second messenger itself, there is tight spatial control of cAMP and it’s 
availability is regulated through adenylyl cyclase and phosphodiesterases (PDEs). 
Additionally, specific PDE isoforms have been shown to be coupled to specific GPCRs, 
which allows for a tight level of regulation surrounding cAMP degradation (Benedetto 
et al., 2006).  The conversion of cAMP to AMP by phosphodiesterases represents one 
of the feedback mechanisms responsible for down-regulation of PKA.  
 
1.2.2 Cellular Distribution of PKA 
Type I and type II R subunits have differential tissue distribution and even 
differential subcellular localization. While type I PKA is localized in the cytoplasm, the 
majority of type II PKA is localized to subcellular compartments, through binding to A-
kinase anchoring proteins, which will be discussed in greater detail later. Additionally, 
the R subunits have different affinities for cAMP, which allows for different thresholds 
of activation. Because of the breadth and cellular distribution of PKA substrates, there 
is a large need for its activity to be regulated within the subcellular space. Both through 
anchoring and localized cAMP gradients, there is a dynamic level of regulation to PKA 
activity, allowing for the organization of spatial signaling cascades in response to 
specific stimuli.   
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1.2.3 Role of PKA in Cell Migration 
The role of PKA in cell motility has been studied extensively and well 
characterized as both required for, and detrimental to cell migration (Edin et al., 2001; 
Ydrenius et al., 1997). PKA exerts both positive and negative effects to control 
adhesion, membrane protrusion and retraction, and cytoskeletal dynamics as many 
processes require its activity while others are inhibited (Howe, 2004). While the role of 
PKA in cell migration has been reviewed extensively (Howe, 2004), a few of the 
findings will be presented below.  
 
1.2.3.1 Negative Regulation  
 
PKA has been shown to negatively affect aspects of cell migration. One of the 
classic examples shows that PKA causes inhibition of α5β3-mediated endothelial cell 
migration (Kim et al., 2000). Similarly, Spina et al., reported that PKA inhibits leptin-
induced migration of breast cancer cells (Spina et al., 2012).  While PKA’s negative 
regulation of integrin-mediated cell migration has been well characterized, recently it 
has been shown that PKA may inhibit bladder cancer cell invasion through targeting of 
MAP4-dependent microtubule dynamics (Ou et al., 2014). Additionally, it was recently 
shown that increased levels of PKA activity, achieved through an increase in cAMP 
levels, inhibits migration and invasion of pancreatic ductal adenocarcinoma cells 
(Burdyga et al., 2013). Central to cell migration are actin cytoskeletal dynamics. PKA 
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has been found to inhibit the formation of actin stress fibers in endothelial cells (Liu et 
al., 2001). These observations represent a few mechanisms by which PKA is able to 
inhibit cell migration.  
 
1.2.3.2 Positive Regulation 
 
The requirement and positive effects for both, elevation of cAMP and activation 
of PKA, in cell migration have been well characterized for a number of cell types. It 
was found over a decade ago, that PKA was required for growth-factor stimulated 
migration of fibroblasts (Edin et al., 2001), and this finding became monumental in 
establishing PKA’s role in migration. Subsequently, PKA has been found to facilitate 
leading edge dynamics, specifically PKA activity is required for pseudopod stability 
and formation (Howe et al., 2005), and is required for the formation and attenuation of 
actin-induced membrane ruffles (Howe et al., 2008).  Filopodial and lamellipodial 
formation, additional mechanisms of protrusion, were also shown to require PKA 
activity (Grieshaber et al., 2000; Plopper 2000). Most recently, PKA activity was found 
to be localized to the leading edge of migrating epithelial ovarian cancer cells and 
inhibition of activity prevented migration (McKenzie et al., 2011).    
While the mechanism by which PKA contributes to cell migration has yet to be 
completely elucidated, it is important to point out that PKA has been shown to be 
important or necessary to many processes central to cell migration. For example, PKA 
has been shown to play a role in regulating a number of small GTPases intrinsic to actin 
cytoskeletal dynamics and cell migration such as Cdc42 (Feoktistov et al., 2000), Rac 
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(O’Connor et al., 2001), RhoA (Tkachenko et al., 2011; Chen et al., 2005), and Rap1 
(Takahashi et al., 2013). Additionally, PKA activity has been shown to be required for 
cell migration through its regulation of α4-integrins (Lim et al., 2008; Goldfinger et al., 
2003).  
It has become increasingly clear that the PKA activity observed at the leading 
edge of cells does not simply have a negative or positive effect on cell migration. 
Instead, PKA activity is tightly spatially and temporally regulated such that it is able to 
exhibit an oscillating regulation over the mechanisms of cell migration.   
1.2.4 The Role of PKA in Cell Adhesion 
As mentioned prior, the reciprocal regulation between PKA activity and 
integrins is beginning to be defined (Lim et al., 2008, Goldfinger et al., 2003) thus 
providing evidence for the role of PKA in cell adhesion. PKA has been shown to be 
activated not only in response to integrin-mediated cell-ECM adhesion, but also by 
cellular detachment (Whittard et al., 2001; O’Connor et al., 2001; Howe et al., 2002).  
The activation and inactivation of PKA was actually shown to be both cell type and 
ECM-ligand specific (Whelan et al., 2003). This was shown when PKA activity was 
suppressed in endothelial cells plated on collagen I, thus engaging α1β1	   integrins, but 
not on laminin-1 (Whelan et al., 2003). Additionally, the dichotomous regulation of 
PKA was shown through two experiments which showed that adhesion through the β1	  
integrin suppresses PKA activity during α5β3-mediated endothelial cell migration yet 
activates PKA in carcinoma cells and fibroblasts (Howe et al., 2002; O’Connor et al., 
2001).  
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The connection between PKA and cell-ECM adhesion is further supported by 
the reports of the reciprocal regulation between PKA activity and the α4	   integrin 
(Goldfinger et al., 2003; Lim et al., 2004; Lim et al., 2008). Of particular note is the 
finding that the cytoplasmic tail of the α4	  binds type I PKA in a mechanism distinctly 
different from canonical A-kinase anchoring interactions, which will be discussed in 
detail later (Lim et al., 2008). This localized PKA activity was actually shown further 
by the finding that the PKA-induced phosphorylation of the α4	   cytoplasmic	   tail	  was	  completely	  localized	  to	  the	  leading	  edge	  of	  lamellipodia	  and	  absent	  from	  the	  rear	  of	  migrating	  cells	  (Goldfinger	  et	  al.,	  2003).	  This	  was	  followed	  up	  by	  the	  finding	  that	  this	  phosphorylation	  was	  necessary	  for	  α4β1-mediated migration (Goldfinger et al., 
2003).  
 
1.2.5 Substrates of PKA in Regulation of the Cytoskeleton, Adhesion, and Migration 
The role of PKA in cell migration has been further defined by the identification 
of numerous substrates intimately involved in cytoskeletal dynamics, adhesion, and 
actomyosin contractility. These phosphorylation events have been shown in proteins 
borrowed from structural and signaling classes, representing the breadth of targets in 
which PKA exerts its effects to regulate migration. The list of PKA targets involved in 
migration is extensive and has been well reviewed before (Howe, 2004), therefore the 
subsequent section will cover a fraction of the relative targets in an effort to 
demonstrate PKA’s importance in regulating cell migration.  
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As mentioned previously, of particular note and certainly integral to migration 
and adhesion, the cytoplasmic tail of the α4	   integrin, has been shown to be directly 
phosphorylated by PKA (Lim et al., 2004; Lim et al., 2008).  
 
1.2.5.1 Actin 
 
One of the most elegant examples of PKA’s role in regulating aspects of cell 
migration is exemplified through the direct phosphorylation of actin (Ohta et al., 1999). 
Furthermore it was shown that this phosphorylation led to the decreased ability of actin 
to polymerize (Ohta et al., 1999). While this mechanism has not been further defined, it 
does demonstrate a direct connection between PKA and the actin cytoskeleton. There 
are many ways other, which PKA regulates actin dynamics, which have been well 
characterized, and will be discussed subsequently.  
 
1.2.5.2 Vasodilator-stimulated phosphoprotein (VASP) 
 
The vasodilator-stimulated phosphoprotein (VASP) is a member of the 
cytoskeletal regulatory binding protein family Ena/VASP. These proteins contain 
several domains including an N-terminal EVH-1 domain, a C-terminal EVH-2 domain, 
and a central proline-rich domain (Howe et al., 2002). These domains enable VASP 
family proteins to localize to focal adhesions through binding to vinculin, zyxin, and 
actin itself (Reinhard et al., 2001; Krause et al., 2003; Grange et al., 2013). 
Additionally, VASP family proteins are thought to be required for filopodial formation 
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as they directly and indirectly associate with actin-capping proteins and cross-link actin 
filaments (Lebrand et al., 2004;  Breitsprecher et al., 2011; Pasic et al., 2008). Three 
phosphorylation sites on VASP have been linked to both PKA and PKG, although Ser-
153 has been well characterized as the preferred site for PKA, and has been shown to 
correspond to a decreased ability to nucleate, bind and bundle actin filaments 
(Lambrechts et al., 2000). Furthermore it has been shown that the phosphorylation of 
VASP may disrupt its interactions with additional binding proteins, suggesting a further 
role for PKA in regulating the assembly of critical proteins involved in regulating 
adhesion dynamics (Lambrechts et al., 2000).   
1.2.5.3 Myosin Light Chain (MLC) 
 
Non-muscle myosin II is one of the critical regulators of the actin cytoskeleton 
during cell migration through myosin-contractility and is important for not only leading 
edge dynamics, but also retraction at the rear edge of the cell (Vincente and Horowitz, 
2004). The phosphorylation of myosin through myosin light chain (MLC) regulates its 
activity, specifically the binding to F-actin and myosin-based contractility (Howe). The 
phosphorylation state of MLC is largely regulated through MLC kinase (MLCK) and 
MLC phosphatase (MLCP) activity, and PKA has been implicated in playing a role in 
this dynamic (Verin et al., 1998; Garcia et al., 1997). Although the role of PKA in 
regulating the aforementioned is complex, it nonetheless highlights the central role of 
PKA in cell migration through regulation of a protein central to actin dynamics.  
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1.2.5.4 Filamin A 
 
Filamin A is an important regulator of actin cytoskeletal dynamics. Filamin A 
acts to promote orthogonal branching of the actin-cytoskeleton by binding, stabilizing, 
and bundling F-actin (Razinia et al., 2012). Filamin A is localized to both the 
protruding and retracting edge of migrating cells (Zhou et al., 2010), linking the 
cytoskeleton to the cell membrane and providing mechanical stability to cells. In 
addition to binding actin, filamin A has been shown to interact with over 90 diverse 
cellular proteins, allowing filamin A to act as a scaffolding protein and integrating 
multiple signaling pathways (Zhou et al., 2010).  
Extensive work has been done to demonstrate the role of Filamin A in cell 
adhesion and migration (Kim et al., 2008). As eluded to before, Filamin A has been 
shown to localize to filopodia, lamellipodia, stress fibers, and focal adhesions 
(Campbell 2008). Additionally, filamin A-deficient melanoma cells (M2) exhibit 
decreased motility and decreased adhesion stability (Lynch et al., 2011; Cunningham et 
al., 1992; Baldassarre et al., 2009). Filamin A also regulates integrin-mediated 
lamellipodial formation and extension and cell spreading on collagen in a number of 
cell types (Kim et al., 2008, Byfield et al., 2009).  
Filamin A has been shown to have over 90 binding partners, borrowed from 
many functional classes, yet a number of which are intimately involved in cytoskeletal 
dynamics and adhesion . Of particular interest is the binding to β-­‐integrins,	  which	  as	  described	   earlier,	   are	   essential	   to	   both	   cell	   migration	   and	   adhesion	   (Lim	   et	   al.,	  2008).	  Filamin	  A	  was	  actually	  found	  to	  regulate	  cell	  spreading	  via	  the	  β1-­‐integrin,	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suggesting	  that	   filamin	  A	  may	  modulate	  β1	  integrin	  activity	  directly	  and	  through	  the	   recruitment	   of	   additional	   proteins	   (Byfield	   et	   al.,	   2009;	   Kim	   et	   al.,	   2010).	  Filamin	  A	  has	  also	  been	  shown	  to	  bind	  to	  Rho	  Family	  GTPases	  and	  some	  of	  their	  regulators	   (Stossel	   et	   al.,	   2001),	   specifically	   Rac,	   Rho,	   Cdc42,	   and	   RalA	  (Baldassarre	  et	  al.,	  2009).	  Even	  more,	   it	  was	  shown	  that	  the	   interaction	  between	  Filamin	  A	  and	  RalA	  were	  required	  for	  RalA-­‐induced	  filopodial	  formation	  (Ohta	  et	  
al.,	   1999).	  Filamin	  A	  has	  also	  been	   shown	   to	  bind	  downstream	  effectors	   such	  as	  PAK1	   (Vadlamudi	   et	   al.,	   2002)	   and	   ROCK	   (Ueda	   et	   al.,	   2003).	   While	   the	   list	  continues	  of	   filamin	  A	  associated	  binding	  partners,	   these	  partners	  alone	  provide	  strong	  evidence	  to	  support	  filamin’s	  role	  in	  cytoskeletal	  dynamics	  and	  adhesion.	  	   
Interestingly enough, filamin A has also been shown to be a phosphorylation 
target of PKA (Jay et al., 2000). Subsequent studies showed that this phosphorylation 
event occurs in filamin’s C-terminus at Ser2152 and Thr2336 (Jay et al., 2004). While 
the role of these phosphorylation sites has yet to be completely determined, it is thought 
to have some protection over filamin cleavage (Garcia et al., 2006).  
 
1.2.5.5 Rho Family GTPases 
 
The roles of Rho family small GTPases have been extensively studied and 
reviewed, and therefore a brief summary will be included below.  
Recently, a role for PKA was identified in regulating protrusion-retraction 
cycles at the leading edge of cells. Specifically, the phosphorylation of RhoA on Ser188 
by PKA was critical in controlling migration events at the leading edge of cells 
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(Tkachenko et al., 2011). This evidence showed an alternative mechanism for PKA as 
it had previously been shown to negatively regulate RhoA through Rho-GDI (Qiao et 
al., 2008). Furthermore, over-expression of AKAP-Lbc, which will be discussed in 
more detail later, showed an increase in Rho-mediated stress fiber formation likely by 
coupling to PKA through the G-protein Gα12 (Diviani et al., 2001). Thus this 
mechanism perfectly exemplifies anchorage-mediated PKA regulation over cytoskeletal 
proteins.  
PKA activity is required for both the activation of Rac and Cdc42 (O’Connor et 
al., 2001; Bachmann et al., 2013; Feoktistov et al., 2000). Previously, Rac activity has 
been observed to be localized to the leading edge structures in migrating or protruding 
cells (Aoki et al., 2004).  Work from our lab has shown that in fact inhibition of PKA 
activity inhibited Rac activity through the regulation of Rac-GAP and Rac-GEF (Howe 
et al., 2005). Unlike RhoA however, Rac is not directly phosphorylated by PKA. 
However, it was recently found that Rac1 shows AKAP properties and showed a direct 
interaction with PKA type IIβ	   subunits	   (Bachmann	   et	   al.,	   2013).	   This	   provides	  evidence	   for	   the	   localization	   of	   PKA	   within	   protein	   complexes	   involved	   in	  cytoskeletal	  dynamics	  and	  cell	  migration.	  	  	  
The examples above were given do not fully encompass the multitude of PKA 
substrates however they were intended to give examples of a subset of targets that are 
intimately involved in actin cytoskeletal dynamics and adhesion. As the evidence for a 
role of PKA in cell migration is surmountable, an underlying mechanism is still to be 
elucidated. This mechanism is likely to be very complex, and tightly spatially and 
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temporally regulated. This spatial control is achieved through compartmentalization of 
PKA to distinct subcellular locations through a family of scaffolding proteins called A-
kinase anchoring proteins (AKAPs). Thus anchoring allows spatial control of PKA 
signaling by regulating proximity to its specific substrates in discrete subcellular 
locations as well as providing temporal control through localizing PKA to small 
pockets of cAMP activity. Understanding which AKAPs are responsible for PKA 
anchoring during cell migration and adhesion is of critical importance to understanding 
the mechanism by which PKA is regulated during these fundamental processes.  
 
1.3 A-Kinase Anchoring Proteins 
 
 
1.3.1 The Importance of Scaffolding Proteins 
Cells respond to and convert cues from the extracellular environment to 
intracellular effects through the use of signaling proteins. Many signaling proteins have 
broad substrate specificity, which requires a precise level of regulation to achieve 
efficacy and accuracy. Scaffolding proteins are one of the key mechanisms by which 
the cell coordinates and regulates signaling events. Classically, scaffolding proteins 
were defined as proteins which tether signaling enzymes, promoting their 
communication by proximity, while binding a number of other molecules acting as 
platforms for the assembly of signaling complexes (Alexa et al., 2010).  More recently, 
regulatory roles for scaffolding proteins have been defined using basic mechanisms 
such as proximity, combinatorial binding partners, conformational fine-tuning of pre-
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existing signaling cascades, and offer feedback and feed-forward regulation. One of the 
most appreciated aspects of scaffolding proteins is the ability to create tight spatial and 
temporal organization of signaling complexes, enabling the cell to not rely on simple 
passive diffusion, as a means of transmitting signaling events. One family of well 
characterized, yet diverse, scaffolding proteins are the A-kinase anchoring proteins 
(AKAPs).  
 
1.3.2 Introduction to A-Kinase Anchoring Proteins 
As mentioned before, PKA activity has been seen at the leading edge of 
migrating cells (McKenzie et al., 2011). AKAPs are responsible for the sequestration of 
PKA to these subcellular locations, organizing signaling complexes, and bringing PKA 
within close proximity to target proteins. Additionally, AKAPs are adaptors, which 
allow for the integration of a number of other signaling molecules, providing a 
mechanism for cross talk among diverse signaling pathways.  
AKAPs provide a tight spatial and temporal control, which in turn provides 
enhanced specificity in signal transduction pathways. AKAPs do not only act to direct 
PKA in the cell, but they also couple PKA to its upstream and downstream regulators 
such as adenylyl cyclases and phosphodiesterases. These provide both positive and 
negative control while creating intracellular cAMP gradients culminating in stimulus-
specific activation of PKA.  
The remainder of this review will focus on the description and characterization 
of AKAPs, their mechanism of binding PKA, and their role within cellular dynamics. 
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Particularly, this review will focus on methods to identify and characterize new 
AKAPs.  
1.3.3 AKAP Structure and Function 
AKAPs are a structurally diverse, but functionally similar family of proteins 
that now includes over 50 family members (Tasken et al., 2010). While AKAPs share 
little primary sequence similarities, they all contain a highly conserved secondary 
structural element, which facilitates their binding to PKA. All AKAP family members 
contain three structural elements; a conserved helical PKA anchoring domain, binding 
sites for additional signaling molecules, and subcellular localization signal (Carnegie et 
al., 2004).  
 
1.3.4 AKAP Nomenclature 
Initially, AKAPs were named for their molecular weight identified by SDS gel 
electrophoresis. For example, AKAP79 can be found at 79 kDa in SDS-PAGE. 
However after finding that many AKAPs were fragments and smaller transcripts of 
larger genes, AKAPs were renamed using a sequential numbering system. The most 
recently identified AKAPs such as Ezrin, Rab32, and WAVE-1 have not been included 
in the numbering classification (Pidoux and Tasken, 2010).   
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1.3.5 Localization Signals 
The ability for AKAPs to target PKA and other signaling molecules to distinct 
subcellular regions impinges on each AKAP’s individual targeting motif. AKAPs have 
been found to associate to different subcellular compartments, including the plasma 
membrane, mitochondria, nuclear membrane, and cytoskeleton (Figure 2). In some 
cases, several different AKAPs can be targeted to the same location. For example, both 
AKAP79/150 and Gravin, also known as AKAP250, are both targeted to the plasma 
membrane through phospholipid-binding sequences (Dell’Acqua et al., 1998; Grove 
and Bruchey 2001). Gravin however, is thought to contain an additional N-terminal 
myristoyl group as well (Grove and Bruchey 2001). AKAP18 is thought to target to the 
plasma membrane however this is through dual myristoyl and palmitoyl groups (Trotter 
et al., 1999). AKAP350 and pericentrin are targeted to the centrosome through a motif 
named the pericentrin-AKAP350 centrosomal targeting domain (PACT) (Diviani et al., 
2000; Gillngham and Munro, 2000). At the mitochondria, D-AKAP1, Rab32, and 
WAVE1 are all localized, however while Rab32 and WAVE1 are targeted through the 
prenylation of cysteine residues at their C-termini, D-AKAP1 is localized through a 
more conventional mitochondrial targeting sequence (Huang et al., 1999; Alto et al., 
2002; Danial et al., 2003). Although the subcellular location of many AKAPs has been 
identified, the details and specific targeting motifs have only been identified for a few 
molecules. The presence of multiple AKAPs within the same subcellular compartment 
suggests the need for multiple and distinct signaling complexes within one region of the 
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cell. This mechanism acts to provide tight signaling regulation by enabling PKA to 
phosphorylate a different panel of substrates within the same subcellular location.  
In some cases, splice variants arising from the same gene are often targeted to 
different subcellular compartments. For example, AKAP18 is differentially spliced into 
three isoforms, alpha, beta, and gamma (Trotter et al., 1999; Fraser et al., 1998), and 
each isoform has distinct subcellular distribution. Additionally, AKAP350 can be 
spliced into shorter and longer isoforms (Trotter et al., 1999). The shorter isoforms are 
directed to synaptic membranes, binding to the NMDA receptor, where the longer 
isoforms are directed to the centrosome through the C-terminal PACT domain (Schmidt 
et al., 1999; Witczak et al., 1999). 
 
              
Figure 2: AKAP Signaling Complexes Localize to Distinct Subcellular Regions to Create Focal 
Points for Signal Transduction 
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1.3.6 Mechanism of PKA Anchoring 
One of the defining characteristics of AKAPs is the mechanism by which they 
bind PKA regulatory subunits. This binding occurs through a 14-18 amino acid 
sequence, which forms a highly conserved amphipathic alpha-helix (an alpha-helix with 
opposing polar and nonpolar faces) (Carr and Scott, 1992). The helix coils such that the 
hydrophobic residues of the helix contact the grove formed by the RII dimers (Figure 3) 
(Carr and Scott, 1992).  AKAP-PKA interactions have been elucidated using AKAP 
derived peptides and the dimerization domains of PKA RIIα subunits.  
 
 
Figure 3: Overview of Structures of RII Dimerization Domain in Complex with an 
Amphipathic AKAP Helix (Adapted from Gold, MG., Lygren B., Dokurno, P., Hoshi, N., 
McConnachie, G., Tasken, K., Carlson, CR., Scott, JD., and Barford, D. Molecular basis of AKAP 
specificity for PKA regulatory subunits. Molecular cell 24, 383-395 (2006)) 
 
The conserved amphipathic helix was first identified over 20 years ago through 
sequence comparisons between some of the first identified AKAPs, Ht31, Map2, Ht21, 
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and P150. While sequence comparison revealed little overall homology, all RIIα 
binding regions revealed a conserved glutamic acid at position 3. Comparing the polar 
and nonpolar residues in these regions, showed a strong alignment of types of 
hydrophilic and hydrophobic residue types (Figure 4). Furthermore, when using a 
helical wheel projection for each of the sequences, hydrophilic and hydrophobic amino 
acids became grouped on opposing faces of the helix. No other sequences in the 
proteins could be similarly aligned, suggesting the functional significance of these 
regions within each of these proteins (Carr et al., 1991).  Mutagenesis of amino acid 
residues within the putative RIIα binding region of Ht31 disrupted the secondary 
structure of the helix and abolished PKA binding, highlighting the importance of the 
helical structure (Carr et al., 1991). Furthermore, introduction of proline residues 
outside of the putative PKA binding region had no effect on binding. The amphipathic 
helix motif is conserved throughout the AKAP family with the exception of pericentrin 
(insert refs). NMR structural analysis confirmed the helical structure of the AKAP RIIα 
binding domain when in complex with the RIIα dimer (Newlon et al., 2001).  
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Figure 4: Sequence Alignment and Conservation of Hydrophilic and Hydrophobic Residues 
Among Known AKAPs 
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of the RIIα dimerization domain showed the formation of a four-helix bundle with two 
protomers forming an antiparallel conformation with their N-termini (Gold et al.,  
2006; Newlon et al.,  1999; Newlon et al., 2001; Kinderman et al., 2006). This well-
ordered four-helix structure is maintained through extensive hydrophobic interactions 
(Figure 5) (Newlon et al., 1999). These hydrophobic residues are also responsible for 
creating the extended hydrophobic grove of the RIIα dimer interface, necessary for 
AKAP binding. Mutations in hydrophobic residues in either the RIIα dimer or within 
the AKAP RIIα binding domain diminish or abolish binding, suggesting the importance 
of the hydrophobic residues for maintaining PKA anchoring (Miki and Eddy, 1999). 
Specifically, mutagenesis studies identified isoleucines at position 3 and 5 within the 
RIIα dimerization domain that are important for AKAP binding (Hausken et al., 1994; 
Hausken and Scott, 1996).    
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Figure 5: Details of the AKAP Helix-RIIα Dimerization Domain Polar Contacts (Adapted from 
Gold, MG., Lygren B., Dokurno, P., Hoshi, N., McConnachie, G., Tasken, K., Carlson, CR., Scott, 
JD., and Barford, D. Molecular basis of AKAP specificity for PKA regulatory subunits. Molecular 
cell 24, 383-395 (2006)) 
 
1.3.7 Type I vs. Type II Anchoring 
While the majority of AKAPs identified to date bind PKA type II, type I 
binding has been well established and characterized. Additionally, dual-specificity 
AKAPs (D-AKAPs) are able to bind both type I and type II regulatory subunits (Huang 
et al., 1997; Huang et al., 1999). Many dual-specificity AKAPs, while able to bind both 
types of subunits, often bind RI subunits with 10-100-fold lower affinity than RII 
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(Welch et al., 2010). For example, binding assays of D-AKAP1 with all four isoforms 
of PKA revealed binding to RIIα and RIIβ at KD=0.5nM compared to a KD=185nM for 
RIα and RIβ (Stokka et al., 2006). Rate constants for AKAP79 binding to all four 
regulatory subunits were also identified revealing higher affinity binding to RIIα and 
RIIβ, indicating this is not unique to D-AKAP1 (Stokka et al., 2006).  
NMR structural analysis of the RIα dimerization domain reveals some subtle 
structural differences between RIα and RIIα within the N-terminus. The structure of the 
RIα dimerization domain (D/D) is similar to that of RIIα, forming the four-helix bundle 
with the major difference existing at the extreme N terminus. Within the RIIα dimer, 
the extreme N-terminus is extended (Newlon et al., 1999; Newlon et al., 2000), where 
in RIα it forms a helical structure (Banky et al., 2000). This helical structure partially 
occludes the AKAP binding surface and is therefore responsible for the observed 
differences in AKAP binding among RIα and RIIα (Banky et al., 2003). Further 
characterization of the RIα extreme N-terminus shows this region to contain more 
charged residues than that of RIIα (Banky et al., 2000) disrupting the hydrophobic 
groove of the AKAP binding surface. The presence of these charged residues within the 
AKAP binding region provides evidence for an alternative RIα AKAP binding 
mechanism, which involves stabilization through acidic and basic residues with the 
addition of an electrostatic component (Burns et al., 2003). Solution structures of the 
D/D of RIα showed the formation of a deep cleft maintained by disulfide bonds in 
contrast to the hydrophobic groove formed by the D/D of RIIα (Banky et al., 2003; 
Sarma et al., 2010).  
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It was recently shown that dual-specificity AKAPs contain an additional PKA 
binding element, which is located outside of the conserved amphipathic helix (Jarnaess 
et al., 2008). In vitro binding experiments with the dual-specific AKAP ezrin, identified 
this region as the RI specifier region upstream of the canonical helix (Jarnaess et al., 
2008). Sequence alignments of other known dual-specificity AKAPs including D-
AKAP1, D-AKAP2, PAP7, and Merlin revealed the presence of this conserved region. 
Furthermore, classical RII AKAPs such as AKAP-Lbc and AKAP79 do not contain this 
region, suggesting the specificity for RI binding (Jarnaess et al., 2008).  
 
1.3.8 Noncanonical AKAPs 
Not all AKAPs bind to the dimerization domain through an amphipathic helix 
(Skroblin et al., 2010). There are a few noncanonical AKAPs which have been 
identified, however few are known likely due to the fact that they are missed in screens. 
Pericentrin is the best characterized noncanonical AKAP, whose binding to PKA RIIα 
is facilitated through a non-helical, 100 amino acid, leucine-rich region (Diviani et al., 
2000). Additionally, the α4 integrin cytoplasmic domain, which is not predicted to form 
an α-helix, interacts with type I PKA in a manner that is not disrupted by Ht31 
disruptor peptides (Lim et al., 2007). This suggests a noncononical mechanism of PKA 
anchoring. It is possible that this noncanonical binding may provide an additional level 
of PKA regulation and the potential for many AKAPs to be uncovered. 
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1.3.9 Evolution of AKAPs 
The majority of the currently identified AKAPs have been found from human or 
rat origin (Scott et al., 2013). However, orthologs of a number of mammalian AKAPs 
were also found in lower vertebrates such as Xenopus (Isoldi et al., 2010; Klingbeil et 
al., 2001; Park et al., 2007; Semenova et al., 2009) and Danio rerio (Goehring et al., 
2007; Reynolds et al., 2007). AKAPs have also been identified in invertebrates such as 
the nematode Caenorhabditis elegans and the fruit fly Drosophila melanogaster (Angelo 
and Rubin, 1998). AKAPs have even been identified in the unicellular green algae, 
Chlamydomonas reinhardtii (Gaillard et al., 2001). There is little known about AKAPs 
in invertebrates, and it is most likely that there are a larger number of AKAPs 
expressed in vertebrates. Thus giving rise to their role in the regulation of large 
signaling processes required for specialized cell functions and cell-cell communications 
in complex multicellular organisms. The current knowledge shows the mechanism of 
PKA anchoring is similar across species, suggesting the highly conserved and 
indispensable role for AKAPs.     
 
1.3.10 AKAPs as Organizers of Multivalent Complexes 
While the most appreciated and biologically significant role of AKAPs is their 
interaction with PKA, an additional feature of these molecules is their ability to bind a 
number of other signaling enzymes. Thereby allowing AKAPs to form multivalent 
signaling complexes. In many cases, AKAPs bind enzymes with opposing actions such 
as kinases and phosphatases, defining their role as regulators of both signal transduction 
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and signal termination. Two of the most well characterized examples of this are 
AKAP79 and AKAP220, as they bind to PKA and either calcium-calmodulin-
dependent phosphatase (PP2B, also known as calcineurin) (Klauck et al., 1996) or 
protein phosphatase 1 (Schillace et al., 1999) respectively. Furthermore, AKAP79 has a 
capacity to bind a number of other proteins involved in signaling, which allows for the 
formation of customized and localized signaling complexes to the plasma membrane in 
a number of different cell types (Carr et al., 1992). Targeting enzymes to the cell 
periphery therefore positions them in a way, which enables them to respond to pools of 
intracellular second messengers such as cAMP, calcium, and phospholipids. In fact, 
AKAP79 has been shown to be one of the anchoring proteins, which targets PKA to β-
adrenergic receptors to play a role in their phosphorylation-mediated down-regulation 
(Fraser et al., 2000). AKAP79 has also been shown to physically associate with 
adenylyl cyclase 5 terminating cAMP synthesis upon phosphorylation (Bauman et al., 
2006).  
Multiple signaling pathways can be integrated via a single AKAP complex. 
Interestingly, AKAP79/150 is also able to coordinates protein kinase C mediated 
signaling events (Navedo et al., 2008). These findings suggest the flexible and dynamic 
role AKAPs and their ability to be involved in a number of signaling events, allowing 
for crosstalk and large coordination of multivalent complexes.  
Another aspect of AKAPs is their ability to anchor enzymes to selected 
substrates. This therefore facilitates signal transduction through the dual anchoring of 
both enzymes and specific substrates within distinct subcellular regions. The functional 
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implication of which is rapid and highly regulated signal transduction. Instead of 
relying on diffusion of proteins involved in signaling cascades, AKAPs create pockets 
of signaling complexes. Phosphorylation of proteins in one of the universal means of 
intracellular communication and one in which requires a high level of regulation. 
Although the physiological roles of anchored PKA phosphorylation events have been 
elucidated in a number of cell types, the organization and operation of individual 
protein complexes within AKAP complexes has yet to be defined. Even more, the 
functional significance of effects on substrate phosphorylation when PKA anchoring is 
disrupted has yet to be elucidated.  
 
1.3.11 Regulation of Signaling Complexes/Context Dependent Complexes 
As AKAPs are continually characterized, and their binding partners elucidated, 
it has become obvious that a single anchoring protein is able to interact with only a 
small subset of proteins at any given time. However, there exists great potential in the 
ability to organize different enzyme combinations and therefore the repertoire of signals 
that are processed through a single AKAP. This complexity can be expanded through 
context specific regulation, either at specific compartments within the cell or through 
tissue-specific cues.  
The WAVE family of proteins (WAVE1, 2, 3) coordinate different signaling 
complexes at both the compartment and tissue-specific level. For example, in neurons, 
growth-factors stimulate WAVE1 bound Rac to cause actin reorganization (Miki et al., 
1998). However in hepatocytes, WAVE1 is involved in the regulation of PKA 
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phosphorylation of BCL2, contributing to apoptosis (Danial et al., 2003). Within the 
same cell, there is differential targeting of AKAP isoforms to distinct subcellular 
locations. This allows for the regulated distribution of PKA to discrete pockets of 
substrates. For example, yotaio can be associated with the plasma membrane, targeting 
PKA to channels and receptors such as the NMDA receptor (Westphal et al., 1999) 
while the longer splice variants are targeted to the Golgi apparatus (Shanks et al., 
2002). These vastly different mechanisms for single AKAPs within different cellular 
contexts allows for the expansive roles of AKAPs and implicates their importance in 
the coordination of signaling. 
The recruitment and release of binding partners can also be determined by 
covalent modifications, thereby modulating not only the composition of signaling 
complexes but also the activity of anchored enzymes. Phosphorylation has been shown 
to regulate both the binding to and release of proteins from AKAPs (Carnegie et al., 
2004; Carlisle-Michel et al., 2004; Diviani et al., 2000; Kapiloff et al., 1999). 
Specifically, it has been shown that phosphorylation of PDE4D3 increases its affinity 
for the anchoring protein mAKAP (Carlisle-Michel et al., 2004) while PKA mediated 
phosphorylation of AKAP-Lbc disrupts its association with PKD (Carnegie et al., 
2004).  
 
1.3.12 Disruptor Peptides as a Tool for Understanding Anchoring Function 
In order to study the functional roles of AKAPs, peptides that disrupt the PKA-
AKAP interaction have been developed. These have been widely used in the field and 
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have additionally served as important tools in the study of PKA’s functional 
implications in cellular processes. All of the peptides developed comprise the PKA 
binding domain of AKAPs, the 14-18 stretch of amino acids forming the amphipathic 
helix. The first anchoring disruptor to be characterized was a 24 amino acid peptide 
from Ht31 (now called AKAP-Lbc) which lies between residues 494-507 (Carr et al., 
1991; Carr et al., 1992). Further characterization of the Ht31 peptide showed this 24 
amino acid stretch is sufficient to disrupt both PKA type I and type II anchoring 
(Herberg et al., 2000). This peptide binds RIIα with low nanomolar affinity (KD=2.2 
nM) (Newlon et al., 2001). Second-generation disruptors were later developed in order 
to distinguish between RI and RII AKAP interactions (Burns-Hamuro et al., 2003; Alto 
et al., 2002; Carlson et al., 2006; Gold et al., 2006).  
 
 1.3.12.1 Type I Specific Disruptor: RIAD 
 
A peptide derived from D-AKAP2, a known dual-specific AKAP, was used as a 
template to design a specific RIα disruptor (Burns-Hamuro et al., 2002). Truncations 
and amino acid substitutions were made to identify critical residues and minimal length 
requirements for bindings and regulatory subunit binding affinity was assessed by 
SPOT synthesis (Burns-Hamuro et al., 2002). Using both bioinformatics and a peptide 
array screening, this peptide was further characterized and a higher affinity binding 
peptide called RIAD (RI anchoring disruptor) was developed which has 1000-fold 
higher selectivity for type I PKA than type II PKA (Carlson et al., 2006).   
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1.3.12.2 Type II Specific Disruptors: AKAP-IS and sAKAP-IS 
 
Just as a specific type I disruptor was created, a specific type II disruptor was 
also created. Through a combination of bioinformatics, screening of peptide arrays, and 
RII overlay assays, a high-affinity RII binding peptide was created, called AKAP-in 
silico (AKAP-IS) (Alto et al., 2003). In vitro binding assays showed that the AKAP-IS 
had subnanomolar affinity for RII and was more effective at displacing RII from 
AKAP79 than the Ht31 peptide (Alto et al., 2003). Furthermore, a scrambled form of 
this peptide was shown to have no affect the subcellular distribution of PKA in cells 
(Alto 2003). The AKAP-IS peptide was later optimized by analysis of 340 AKAP-IS 
peptide derivatives where each residue in the sequence was replaced by all 20 amino 
acids. RI and RII binding was assessed using RIα-P32 and RIIα-P32 overlays (Gold et 
al., 2006). The resulting peptide, named SuperAKAP-IS, contained amino acid 
substitutions which both increased the RII binding affinity and decreased the RI 
binding affinity. This peptide, exhibits a 4-fold higher affinity for RIIα and 12.5-fold 
reduced affinity for RIα compared to the AKAP-IS (Gold et al., 2006).  
Modifications such as affinity tags, fluorescent dyes, or cell-penetrating tags 
have been made to these peptides to expand their experimental usability. While these 
peptides have been widely used experimentally, they do have their limitations. The 
global disruption of PKA anchoring within the cellular context liberates PKA, creating 
excessive amounts of free PKA in the cytoplasm, which can result in irregular 
phosphorylation of substrates. Additionally, the modifications of these peptides can 
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result in the uneven distribution within the cell, leading to their enrichment in some 
subcellular locations.  
1.4 AKAPs at the Cytoskeleton 
 
1.4.1 Introduction of AKAPs at the Cytoskeleton 
As mentioned earlier, the actin cytoskeleton is essential for a number of 
biological processes. Our lab and others have shown that PKA is essential for cell 
migration and that PKA is critical for regulating actin cytoskeletal dynamics 
(McKenzie et al., 2011; Howe et al., 2004; Rivard et al., 2009). Due to the breadth of 
its targets and their subcellular localization, the need for focusing and directing PKA to 
specific cellular compartments is essential. Our lab has shown that PKA is spatially 
regulated during cell migration, and more specifically is enriched in protrusive leading 
edge structures.   
There are a number of cytoskeletal proteins that have been shown to be 
substrates for PKA. Additionally, the phosphorylation of which has been shown to be 
essential for regulating their function, particularly in the role of cell migration. Many 
hallmarks of cell migration and cytoskeletal dynamics have been shown to require PKA 
activity (Rac, Cdc42, microfilament assembly), while others are inhibited by PKA 
(Rho, p21 activated kinase, VASP). Integrin dependent endothelial cell migration is 
both positively and negatively regulated by PKA. These observations implicate the 
critical role for PKA in regulating cell migration.  
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The combination of complexity of cytoskeletal dynamics, diversity and breadth 
of PKA’s targets, and PKA’s role in regulating cell migration/actin cytoskeletal 
dynamics underscores the importance of PKA’s localization in the aforementioned. It is 
clear that PKA is neither a positive nor a negative regulator, but rather cytoskeletal 
dynamics/cell migration requires a balance of PKA activity tightly spatially and 
temporally regulated. Given the function of AKAPs as scaffolding proteins for multiple 
signaling enzymes and as anchors for PKA, it is likely that there are AKAPs within the 
cytoskeleton/adhesions responsible for anchoring PKA to sites where it can regulate 
cytoskeletal dynamics/migration.  
 
1.4.2 Cytoskeletal AKAPs 
There are several AKAPs to date which have been identified as being involved 
in actin cytoskeleton dynamics including, AKAP-Lbc/AKAP13 (Diviani et al., 2006; 
Cavin et al., 2014; Klussmann et al., 2001), gravin (Gelman et al., 1998), ezrin 
(Dransfield et al., 1997; Bosanquet 2014), and the WASp and verprolin homology 
protein-1 (WAVE1) (Yamazaki et al., 2005; Takenawa 2005; Takenawa and Miki 
2001).  
 
1.4.2.1 Gravin 
 
Gravin, also known as AKAP12, was originally identified in a screening of 
endothelial cell expression library with serum from a myasthenia gravis patient 
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(Gordon et al., 1992). A few years later, it was shown to be a RIIα specific AKAP 
which could also bind to PKC, beta2 adrenergic receptor, PDE4D, and Ca2+/calmodulin 
(Nauert et al., 1997; Fan et al., 2001; Malbon et al., 2004; Willoubuy et al., 2006). It is 
now well appreciated that Gravin plays a role in cellular adhesion, migration, 
cytoskeletal dynamics, and maintenance of the cytoskeletal architecture (Akakura and 
Gelman 2012). The C-terminal domain of Gravin is required for targeting PKA to the 
cell periphery (Yan et al., 2009). Gravin has been described as attenuating and 
inhibiting chemotaxis and cell invasion (Busch et al., 2008; Gelman et al., 2000) and 
likely through differential activation of both PKA and PKC (Su et al., 2013). Gravin 
has also been shown to be intimately involved in FAK-mediated signaling (Gelman) 
and playing a role in FAK-mediated adhesion and motility pathways (Su et al., 2013). 
Even more, Gravin has been shown not only to bind to the actin cytoskeleton (Gelman 
et al., 2012) but also act as regulator of its architecture, regulating the formation and 
maintenance of stress fibers (Lin et al., 2000). Taken together, these observations 
demonstrate the critical role Gravin plays in actin cytoskeleton dynamics during cell 
migration.    
 
1.4.2.2 WASP family verprolin homologous protein 1 (WAVE1) 
 
WAVE1 is one of the Wiskott-Aldrich syndrome protein family members 
(Takenawa and Miki 2001). WAVE1 directly binds to actin and is intimately involved 
in actin dynamics, both through Rac-1 mediated actin reorganization (Miki et al., 1998) 
and by coupling Rho GTPases to the Arp2/3 complex (Higgs et al., 1999; Machesky 
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and Gould 1999). Recently, WAVE1 was identified as an AKAP and of particular note 
is the finding that pools of WAVE1 localize from focal adhesions to sites of actin 
reorganization upon PDGF treatment (Westphal et al., 2000). Furthermore, Westphal et 
al., showed that upon treatment with PDGF, PKA also localizes to sites of actin 
reorganization (Westphal et al., 2000). A unique feature about the PKA-WAVE1 
interaction is that actin may compete for the RII binding site (Westphal et al., 2000). 
The highly dynamic WAVE1-mediated complex formation is a possible mechanism 
used by the cell to both regulate the activity and location of PKA and coordinate actin 
reorganization thus cytoskeletal dynamics following Rac activation. Not only does 
WAVE1 bind PKA RII subunits, but it also has the ability to bind the c-Abl tyrosine 
kinase, forming a multi-signaling enzyme complex (Westphal et al., 2000). This dual 
binding ability of WAVE1 is particularly interesting given that PKA has been shown to 
phosphorylate VASP and cause its uncoupling from Abl (Howe et al., 2002) suggesting 
PKA plays a central role in the regulation of complexes at sites of WAVE1 mediated 
actin reorganization.  
 
1.4.2.3 Ezrin 
 
Ezrin is a member of a superfamily of cytoskeletal associated proteins including 
merlin, radixin, moesin, and talin (Algrain et al., 1989; Bretscher et al., 2002). These 
proteins share homology in their N-terminus which has been implicated in their 
membrane associations (Arpin et al., 1994). Ezrin is part of a smaller subfamily of 
proteins, the ERM family, including radixin and moesin, which share homology across 
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the sequence (Salto et al., 2012). Experiments have shown the binding of PKA RII to 
Ezrin to disrupted using the Ht31 anchoring disruptor peptide (Dransfield et al., 1997). 
These results, taken with further characterization of the PKA bidning domain on Ezrin, 
have identified it as a bonafide AKAP (Dransfield et al., 1997). Of particular interest is 
that the C-terminal domain of ezrin has been implicated in the association with actin 
filaments (Hanzel et al., 1991). Therefore it is likely that Ezrin plays a role in anchoring 
PKA to the actin cytoskeletal, possibly providing an avenue for which PKA could 
regulate actin dynamics.  
1.4.2.4 AKAP-Lbc (AKAP13) 
 
AKAP-Lbc is a unique cytoskeletal associated AKAP as it not only anchors 
PKA but it has the ability to modulate the Rho GTPase (Klussman et al., 2001). In vitro 
experiments identified AKAP-Lbc as a guanine nucleotide exchange factor (GEF) with 
a specificity towards Rho and not Rac or Cdc42, implicating its ability to regulate stress 
fiber and focal adhesion formation (Diviani et al., 2001). Furthermore, the Rho-GEF 
activity of AKAP-Lbc was found to be bi-directionally regulated via G-protein Gα12 
activation and inactivation through PKA-induced phosphorylation and 14-3-3 protein 
binding (Diviani et al., 2004; O’Connor et al., 2012). Taken together this highlights a 
mechanism by which PKA and Rho signaling pathways are integrated through 
scaffolding via AKAP-Lbc. Given what is known about Rho’s regulation of the actin 
cytoskeleton, this provides a likely mechanism for PKA’s regulation over cytoskeletal 
dynamics. Further experiments demonstrated a role for AKAP-Lbc in establishing and 
maintaining PKA gradients (Paulucci-Holthauzen et al., 2009). This in conjunction 
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with the well-established role of compartmentalized PKA activity in cell migration 
implicates AKAP-Lbc’s intimate involvement in regulating cell migration.  
The multiple identified actin-associated AKAPs highlights the importance for 
both PKA activity and the regulation of that activity at sites of actin reorganization and 
thus processes requiring cytoskeletal dynamics. This taken together with the myriad of 
known PKA substrates involved in actin cytoskeletal dynamics, adhesion, and 
migration, support the critical role of PKA activity in regulating such processes.   
   
1.5 Methods for Detecting A-Kinase Anchoring Proteins 
 
 
The design of specific anchoring disruptor peptides has advanced the field’s 
understanding of A-kinase anchoring and ability to identify novel AKAPs. However, 
before the inception of these peptides, AKAPs were identified using more traditional 
methods used, all of which had their limitations.  
1.5.1 Identification of the First AKAP 
The first described AKAP was microtubule associated protein 2 (MAP2) and 
was found rather serendipitously as a molecule that co-purified with the regulatory 
subunit of PKA on cAMP-agarose affinity columns (Theurkauf and Vallee, 1981). 
Detailed study of PKA anchoring was achieved after the observation that many AKAPs 
retained their ability to bind RII after transfer to nitrocellulose (Keryer et al., 1993).  
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1.5.2 RII Overlay 
This observation prompted the development of the RII overlay technique where 
proteins are separated by SDS-PAGE electrophoresis, transferred to nitrocellulose, and 
subsequently incubated with 32P-labeled RII probe (Carr and Scott, 1992). This 
technique, called a far-western or RII-overlay, is essentially a modified western blot, 
and has been widely used by many laboratories for the detection of AKAPs. Extending 
this technique further, Rubin and colleagues used RII to screen cDNA expression 
libraries and since eight AKAPs cDNAs have been identified and characterized with 
this method (Ludvig et al., 1990). These methods have their limitations however. Due 
to the strong denaturing conditions used in SDS-PAGE, which causes protein 
misfolding, a number of AKAPs often lose their ability to bind RII, resulting in missed 
interactions.  
 
1.5.3 Band-Shift 
These limitations allowed for use of band-shift analysis as a means of 
identifying AKAPs. This technique examines protein-protein interactions under non-
denaturing conditions and takes advantage of the differential motility that protein 
complexes exhibit compared to their individual components (Carr and Scott, 1992). 
This led to the demonstration that AKAPs bind to the RII subunit, regardless of the 
association with the catalytic subunit (Carr and Scott, 1992). Not unlike the far-western, 
this technique has its limitations. One of which is the requirement of high 
concentrations of protein for detection and the disruption of equilibrium conditions 
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during electrophoresis. The combination of these techniques with the use of disruptor 
peptides such as Ht31, became standard within the field.  
 
1.5.4 Immunoprecipitation 
Co-immunoprecipitations (co-IPs) and cross-linking IPs have been classically 
used as a method for identifying protein-protein interactions and are often used for 
characterizing PKA-AKAP interactions. Co-IPs are often used as a way to affinity 
purify a protein and characterize its associated binding partners. However this approach 
often misses weak, less abundant and transient interactions. Additionally, co-IP data is 
commonly misinterpreted as proof of direct protein-protein interactions, and is rarely 
followed up with the correct experiments to prove such a conclusion. Another 
limitation to co-IPs is the stringency of the conditions under which the experiment is 
taking place, which can often disrupt native protein interactions, causing them to be 
undetected. Inherent in these experiments is the nature of the antibody-target 
interaction, which itself is subject to harsh conditions as well as the potential, and 
reality, of non-specific binding.   
Chemical crosslinking and crosslinking IPs by contrast, were implemented as a 
way to improve upon the traditional co-IP. Due to the formation of covalent bonds, they 
are often more suitable for capturing transient and low-affinity interactions.  However, 
this method is highly non-specific and often results in the aggregation of multi-protein 
complexes, which present solubility problems in downstream applications.  
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1.5.5 Bioinformatics 
Within the past decade, bioinformatics has allowed for significant progress in 
the field of AKAP identification and characterization. Bioinformatic screens in 
conjunction with peptide overlays and traditional methods have allowed for large 
screens leading to the identification of novel AKAPs (Hundsrucker et al., 2010). This 
approach has its limitations however, one of which is the high number of false positives 
detected simply through searching for proteins containing the AKAP consensus 
sequence. Additionally, the presence of the canonical AKAP sequence alone does not 
sufficiently provide indication of an AKAP, but instead is suggestive and further 
structural considerations must to given to the sequence. More specifically, as described 
previously, the consensus sequence often forms an amphipathic alpha-helix motif to 
mediate PKA-AKAP binding. Searching for a simple consensus sequence search will 
not take this structural requirement into consideration, therefore generating many false 
positives.  
1.5.6 Anchoring Disruptor Peptides 
The generation of both RIAD and sAKAP (is) have allowed for the ability to 
distinguish between type I and type II anchoring. However, these peptides have their 
limitations as they do not allow for the contributions from individual AKPAs to be 
elucidated within the cellular context. These difficulties were the impetus for 
developing a structure-based phage selection strategy, which creates RII subunit 
fragments with selective binding to individual AKAPs, therefore enabling the 
examination of individual AKAPs (Gold et al., 2013). 
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Given the limitations and antiquity of the aforementioned techniques, a need to 
develop new methods with higher selectivity, specificity, and applicability within the 
cellular context has been well established. This thesis aims to optimize and characterize 
a new method for detecting AKAPs. Using a combination of both biochemical 
techniques and large-scale proteomics, this method focuses on a novel technique to 
identify putative AKAPs. This body of work describes first the application of this 
technique in whole cell extract, and later extends the application to cellular 
fractionations enriched with cytoskeletal and adhesion proteins to identify AKAPs 
involved intimately in cytoskeletal dynamics, adhesion, and cell migration.  
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CHAPTER 2: Materials and Methods 
2.1 Cell Culture 
SKOV-3 and HEK293 cells were obtained from American Type Culture 
Collection and maintained in antibiotic-free Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 10% (vol/vol) fetal bovine serum (FBS). All cells for lysis 
were grown in 10cm dishes coated with 10µg/µL human fibronectin at 37°C in a 
humidified incubator containing 5% CO2.  
2.2 Antibodies and Other Reagents 
Primary antibodies were obtained commercially from Millipore (Actin C4, 
filamin A), BD Transduction Laboratories (AKAP79, Ezrin, Lamin A/C, paxillin 
clone349,), Cell Signaling (GAPDH), Santa Cruz Antibodies (PKA RIIα, AKAP79) 
and Sigma (Tubulin DM1α). DMSO was acquired from Sigma (St. Louis, MO). 
Horseradish peroxidase-conjugated secondary antibodies were from Calbiochem, with 
the exception of horseradish peroxidase-conjugated streptavidin, which was from 
Thermo Fisher Scientific. Human fibronectin was acquired from BD Biosciences 
(Bedford, MA). Sulfo-SBED Biotin Label Transfer Reagent was purchased from Pierce 
(Rockford, IL). Dynabeads® Myone ™ Streptavidin T1 beads, Dynabeads® Protein G, 
and DynaMag™ were acquired from Life Technologies (Thermo Fischer Scientific). 
Pharmacological inhibition of PKA anchoring was achieved using Ht31 (aka AKAP-
Lbc) from Sigma-Genosis, a peptide comprising the PKA R-subunit binding domain. 
Ht31 acts as a competitive inhibitor of the interaction between AKAPs and both RIIα 
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and RIα PKA subunits (Gold). The Ht31 and Ht31P synthetic peptides contained the 
sequences LIEEAASRIVDAVIEQVK and LIEEAASRPVDAVPEQVK respectively, 
were diluted in MMQ H2O and stored at -20°C. IPTG acquired from Thermo Fisher 
Scientific (Waltham MA). Duolink® PLA reagents were obtained from Sigma (St. 
Louis, MO).  
2.3 RIIα Purification 
BL21 (DE5) PLysS bacteria containing pET28(b)-RIIα(WT) plasmid were 
inoculated into 5mL Terrific broth containing 1x kanamycin and 34µL chloramphenicol 
(from 147x stock). Inoculations were placed at 37°C shaking for 6-8 hours and 
subsequently back inoculated into a 25mL culture of Terrific broth containing 1x 
kanamycin and 170µL chloramphenicol (from 147x stock). Culture was let shake at 
37°C shaking overnight. The following day, culture was back inoculated into a 1L 
culture of terrific broth with 1x kanamycin and 6.8mL chloramphenicol (from 147x 
stock) and put at 37°C shaking until OD600=0.6-0.8 (1mL of culture was removed 
before induction to be used for subsequent immunoblotting and coomassie staining).   
Induction of bacteria: IPTG was added to a final concentration of 1mM in 
culture and let shake for 4h at 37°C. 1mL of culture was removed at each 1h interval to 
be used for subsequent immunoblotting and coomassie staining. Cells were pelleted at 
4,000xg for 10’at 4°C. Supernatant was removed and saved. 40mL cold lysis buffer 
(recipe described subsequently) was added to pellet was resuspended. Cell suspension 
was sonicated 5x10sec, with a 15sec interval between each sonication. Culture was then 
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spun down at 18,000xg for 15’ at 4°C. Supernatant was removed and put on ice, pellet 
was discarded.   
Batch Binding: In large tube, lysis buffer and cAMP agarose beads were mixed 
(5:1 v/v) (Sigma) and gently resuspended. Beads were spun at 500xg for 5’ at 4°C (or 
until beads collect at bottom of tube). Supernatant was removed and this repeated two 
times to thoroughly wash the beads. Lysate added to washed cAMP beads and mixed 
end over end for 16h at 4°C.  
Column Purification: Fresh lysis and wash buffers were made prior to start of  
column preparation. cAMP lysate mixture was spun at 500xg for 5’ at 4°C to collect 
beads at bottom of tube. Supernatant was removed and saved on ice, 100µL was 
removed for SDS-PAGE confirmation. 10mL lysis buffer added to beads and beads 
were resuspended gently. Slurry was poured into a column and beads were let settle for 
1h at room temperature. Lysis buffer was run out into a small beaker, 100µL removed 
for SDS-PAGE confirmation. Beads washed with 5-10 column volumes of lysis buffer, 
lysis buffer+1M NaCl, 10mM MOPS, lysis buffer, 100µL removed at each wash step 
for SDS-PAGE confirmation. Beads eluted with 2 column volumes 100mM cAMP 
diluted in lysis buffer. Eluents were collected in 0.5mL fractions, and 10µL was 
removed from each for SDS-PAGE confirmation. Fractions were frozen at -80°C until 
SDS-PAGE was run to confirm purity of prep. 10µL of each fraction was mixed with 
equal volumes of 2x Laemmli sample buffer and run on 10% SDS-PAGE gel. Gel was 
stained with coomassie-silver stain (recipe listed subsequently) for 15’ followed by 
destaining in MMQ H2O for 1h. Purity of samples was assessed and highest purity 
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elution fractions were pooled for dialysis. Pooled RIIα was dialyzed in 10mM MOPS, 
100mM NaCl, for 1h at room temperature, buffer changed 2x.   
2.4 Conjugating RII to Sulfo-SBED 
Sulfo-SBED multifunctional cross-linker (Pierce, Thermo Fisher Scientific) was 
dissolved in 22µL DMSO. 5-20µg purified RIIα was conjugated to 5µL dissolved 
Sulfo-SBED and incubated for 40’ at room temperature and protected from light. 
Sample was passed over a desalting column (Pierce) and frozen at -80°C in between 
uses.  
2.5 Biotin Transfer 
Lysate was “pre-cleared” as follows: 50-100µg SKOV-3 protein extract was 
incubated with 2:1 v/v streptavidin magnetic beads for 1h at room temperature. Beads 
were pelleted on magnet and supernatant was removed and placed into new ice cold 
microcentrifuge tube. 100µM Ht31 or Ht31P was added to lysate and incubated rocking 
end over end for 1h at room temperature. To lysate, RIIα-Sulfo SBED, 1:200 w/w, 
covered with foil, and incubated for 45’ at room temperature rocking end over end. Foil 
was removed and samples were exposed to UV light (365nm) for 30’ at room 
temperature, mixing and spinning down every 7-8’ to ensure samples were thoroughly 
mixed. DTT was added to a final concentration of 100mM and samples were heated at 
50°C for 30’. Streptavidin magnetic beads were added to samples (after buffer 
exchange in RIPA buffer), 1:2 v/v, and samples were incubated at 1h at room 
temperature rocking end over end. Beads were pelleted on magnet, supernatant was 
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saved and put on ice. To beads, 1mL RIPA buffer was added, vortexed, and placed on 
ice for 1’. Beads were pelleted on magnet for 1’, removed wash and repeated for a total 
of 4 washes. After last wash, all remaining buffer was removed and 40µL 1x Laemmli 
sample buffer was added, beads were resuspended and spun down, and boiled for 10’. 
Beads were pelleted on magnet for 2’ and samples were loaded directly onto 10% SDS-
PAGE gel.  
2.6 Cytoskeletal Preparation 
10cm dishes were coated with 10µg/mL human fibronectin at 37°C for 1h. 
Dishes washed 3x with sterile 1xPBS prior to plating cells. SKOV-3 cells were plated 
and let grow to sub-confluence (~90%) prior to lysing.  
Media was removed from cells and cells were washed gently with Dulbecco’s 
complete 1x PBS. 1.5mL cytoskeleton stabilizing buffer (recipe described below) was 
added to side of dish, rocked gently, and incubated for 4’ on ice. Dish rocked gently 
side to side and contents were pooled, and collected from bottom of dish using a P1000 
pipetteman, fraction labeled “cytoplasmic fraction”. Dish washed gently with 2mL 
cytoskeleton stabilizing buffer and wash discarded. 250µL RIPA buffer containing 
protease and phosphatase inhibitors was added to dish, and rocked back and forth to 
cover entire surface area of dish. Using a rubber police-man, dish was scraped very 
gently (minimal mechanical shearing), and lysate pooled at bottom of dish. Lysate 
removed carefully and spun at 100xg for 5’ at 4°C. Supernatant removed and 
transferred to new ice-cold tube and labeled “cytoskeletal fraction”. 200µL 1x Laemmli 
sample buffer was added to pellet (“nuclear fraction”) and heated at 75°C for 3-4h.  
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2.7 In-gel Digestion and Liquid Chromatography-Tandem Mass Spectrometry (LC-
MS/MS) 
Extracted biotin-tagged proteins were separated by 10% SDS-PAGE and stained 
with coomassie blue. Following sufficient destain (50mM NH4HCO3 and 50% 
acetonitrile (MeCN), the no RIIα lane, and +/- Ht31 peptide lanes were each cut into 10 
equivalently sized pieces. Each gel slice was cut up further into 1mmx1mm cubes and 
washed with HPLC grade H2O. Pieces were incubated with 700µL desain solution 
(50mM ammonium bicarbonate and 50% MeCN) for 30min at 37°C. Destain was 
removed and pieces were subjected to dehydration by adding 100µL 100% MeCN for 
20’. Gel pieces were further dried in a speed vacuum for 5’. Proteins were digested into 
peptides using sequencing grade modified trypsin at a concentration of 12ng/µL in 
50mM ammonium bicarbonate at 37°C overnight (16-18h). The following day, digests 
were centrifuged at 12000xg for 1’ and supernatant was transferred to a 0.6mL tube. 
50µL extract solution A (described below) was added to samples for 1h at room 
temperature. Samples were centrifuged at 12000xg for 15’ and supernatant was 
transferred to a 0.6mL tube (same tube as before). 50µL extract solution B (described 
below) was added to samples for 1h at room temperature. Samples were centrifuged at 
12000xg for 15’ and supernatant was transferred to a 0.6mL tube (same tube as before). 
50µL 100% MeCN was added to tubes for 5-10’ at room temperature. Samples were 
centrifuged at 12000xg for 15’ and supernatant was transferred to a 0.6mL tube (same 
tube as before). Samples in 0.6mL tubes were dried in a speed vacuum for 3-4h and 
stored at -80°C with proteomics facility.  
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2.8 Immunoprecipitations 
For AKAP79 immunoprecipitations, SKOV-3 whole cell extract was first 
treated as biotin transfer (previously described). Subsequently 100µg of protein was 
incubated with 1.4µg anti-AKAP79 (sc-10764) antibody for 2h at 4°C followed by 1h 
at room temperature. Immunocomplexes were incubated with protein G-magnetic beads 
for 1h at room temperature, washed four times with RIPA lysis buffer, resuspended and 
boiled in 40µL of 1x Laemmli sample buffer for 10’.   
For RIIα immunoprecipitations, SKOV-3 or HEK293 100µg whole cell extract 
was incubated with 1.4µg anti-RIIα (sc-908) antibody for 2h at 4°C. Immunocomplexes 
were incubated with protein G-magnetic beads for 1h at 4°C, washed four times with 
RIPA lysis buffer, resuspended and boiled in 50µL of 1x Laemmli sample buffer for 
10’.   
2.9 Western Blotting  
For preparation of whole cell extract, cells were washed twice with ice-cold 
complete Dulbecco’s phosphate buffered saline, then lysed in RIPA lysis buffer 
(150mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl 
sulphate, 50mM Tris, pH 8.0) containing protease and phosphatase inhibitors or m-
RIPA (0.25% sodium deoxycholate, 150mM NaCl, 1mM EDTA, 1.0% NP-40, 50mM 
Tris, pH 8.0). After 10’ on ice, lysates were scraped into ice-cold microcentrifuge tubes 
and centrifuged at 14,000 rpm (in an Eppendorf microcentrifuge) for 10’ at 4°C. 
Protein concentration of the supernatant lysate was determined by bicinchoninic acid 
assay (Pierce). For direct immunoblotting, aliquots of lysate were mixed with 5x 
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Laemmli sample buffer and boiled for 10’ before loading on 10% or 7.5% SDS-PAGE 
gels. Samples were separated with SDS-PAGE followed by transfer to nitrocellulose 
membrane. Membranes were blocked with 5% nonfat dry milk powder in TBS 0.01% 
Tween-20 for 1h at room temperature. Membranes were incubated with primary 
antibody overnight at 4°C. Following incubation with primary, membranes were 
washed in TBS with 0.01% Tween-20 (TBS-T) 5x 5’and incubated with HRP-
conjugated secondary antibody diluted in 5% nonfat dry milk in TBS-T, 1:1250 for 15’ 
at RT. Detection was performed using chemiluminescence (Pierce).  
2.10 Streptavidin-HRP (sA-HRP) Blotting 
For detection of biotinylated proteins using sA-HRP, a protocol was optimized 
from Kyle Roux, Ph.D. at The University of South Dakota. Following transfer of SDS-
PAGE to nitrocellulose, membrane was incubated in BSA blocking buffer (recipe as 
described below) for 20’-30’ shaking at room temperature. sA-HRP was added at 
1:40,000 in 10mL BSA blocking buffer and incubated for 40’ at room temperature 
shaking. Membrane washed 3-4x vigorously with 1xPBS over sink, followed by 5’ 
incubation with ABS blocking buffer (recipe described below), and 5’ incubation with 
ABS+150mM NaCl shaking at room temperature. Membrane washed 3-4 times 
vigorously with 1xPBS over sink. Membrane washed with 2x5’ 1xPBS+250mM NaCl, 
followed by 2x5’ 1xPBS. Detection was performed using chemiluminescence (Pierce). 
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2.11 Immunofluorescence 
For visualization of ezrin, paxillin, FAK, RIIα, and lamin A/C, SKOV-3 cells 
were plated on 10µg/mL fibronectin and were fixed in 3.7% formaldehyde in TBS for 
10’, permeabilized for 10’ in TBS containing 0.25% triton X-100, and blocked with 
TBS containing 3% BSA for 1h at room temperature. Cells were incubated with anti-
paxillin (1:500, BD Transduction), rabbit anti-RIIα (1:200, Santa Cruz Biotechnology), 
mouse anti-ezrin (1:200, BD Transduction), mouse anti-lamin A/C (1:200, BD 
Transduction), or rabbit anti-FAK (sc-558) overnight at 4°C in a humidity chamber. 
The following day, cells were treated with Proximity Ligation Assay probes according 
to manufacturer’s instructions.  
For visualization of filamin A, SKOV-3 cells were plated on 10µg/mL 
fibronectin and were fixed in pre-chilled anhydrous MeOH. Cells were incubated in -
20°C for 20’. Cells were then treated with 3.7% formaldehyde in TBS for 10’ at RT, 
blocked in PBS containing 1.5% BSA for 1h at room temperature. Cells were incubated 
with mouse anti-filamin A (1:400, Millipore) overnight at 4°C. The following day, cells 
were treated with Proximity Ligation Assay probes according to manufacturer’s 
instructions.  
2.12 In Situ Proximity Ligation Assay 
Protein interactions in SKOV-3 cells were studied using an In situ Proximity 
Ligation Assay Kit (Duolink®) from Sigma. Cells were plated on 10µg/mL fibronectin 
coated coverslips and let adhere overnight. Cells were fixed, permeabilized, and 
incubated with primary antibodies as described in immunofluorescence assays. The 
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Proximity Ligation assay was used as recommended by the manufacturer. In short, cells 
were incubated with secondary antibodies with attached nucleotides, including both 
anti-rabbit and anti-mouse coupled to PLUS and MINUS nucleotides respectively. If 
nucleotides were close (less than 30-40nm), and after ligation, a circular DNA strand 
formed. After amplification of the DNA circle and hybridization of fluorescently 
(563nm) labeled complimentary oligonucleotide probes, protein interactions were 
visualized as red dots.  
2.13 Coomassie Staining 
Following electrophoresis, SDS-PAGE gels were stained in 0.006% Coomassie 
Brilliant Blue R-250 (Bio-Rad) in 10% acetic acid for 1h. Destain solution (50mM 
NH4HCO3 and 50% acetonitrile) was used for destaining for 12h, changing destain 
periodically.   
2.14 Lysis Buffers and Other Buffers 
All buffers stored at 4°C unless otherwise indicated. Cytoskeleton Stabilizing 
Buffer contained 10mM MES pH 6.1, 138mM KCl, 3mM MgCl, 2mM EGTA, 0.32M 
sucrose, and 0.5% triton X-100. RIPA (150mM NaCl, 1.0% NP-40, 0.5% sodium 
deoxycholate, 0.1% sodium dodecyl sulphate, 50mM Tris, pH 8.0)  and modified RIPA 
buffer  (0.25% sodium deoxycholate, 150mM NaCl, 1mM EDTA, 1.0% NP-40, 50mM 
Tris, pH 8.0) were used as indicated. RIIα purification lysis buffer contained 10mM 
MOPS (pH 6.9), 100mM NaCl, 1mM DTT, protease and phosphatase inhibitors. BSA 
blocking buffer contained 1xPBS with 1% bovine serum albumin and 0.2% (w/v) 
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Triton X-100. ABS blocking buffer contained 1xPBS with 10% adult bovine serum, 1% 
(w/v) Triton X-100, 150mM NaCl. Extract solution A (for mass spectrometry) 
contained 5% formic acid. Extract solution B (for mass spectrometry) contained 5% 
formic acid 50% MeCN.  
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CHAPTER 3: Results 
3.1 Results 
 
3.1.1 Model for application of the biotin transfer method 
There is surmounting evidence from our lab and others, demonstrating discrete 
pockets of PKA activity at the leading edge of cells. Additionally, our lab has shown 
that disruption of the AKAP-PKA interaction, with the use of anchoring disrupting 
peptides, leads to a decreased ability of SKOV-3 cells to migrate (Mckenzie et al., 
2011). Therefore, we sought to generate a method for searching for and identifying 
leading edge AKAPs, which may be responsible for type II anchoring of PKA, thus 
responsible for the observed PKA activity. With the limitations and advantages of 
classically used techniques, we created a method based on the use of purified PKA RIIα 
and the use of a commercially available sulfo-SBED biotin transfer reagent (Fig. 1). 
Because biotin is relatively uncommon in vivo, and it is amenable to selective isolation, 
it became an obvious choice for the modification on which we chose to focus.   
Sulfo-SBED is an abbreviation for Sulfo-N-hydroxysuccinimidyl-2-(6-
[biotinamido]-2-(p-azidobenzamido)-hexanoamido) ethyl-1,3’-dithioprprionate. It is a 
heterobifunctional chemical crosslinker, with an amine-reactive NHS ester group at one 
end, capable of binding to any lysine group. On the other arm, there is a UV light-
activatable azide group, which crosslinks non-specifically to any protein side chains. 
What makes this method distinguishable from other chemical crosslinkers, are the 
biotin group and cleavable disulfide bond. Together, these groups lend the ability to 
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Figure 1: Schematic for application of the biotin transfer reagent coupled to RIIα in SKOV-3 
cells 
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Figure 1: Schematic for the application of biotin transfer coupled to RIIα method 
in SKOV-3 cells. RIIα was purified from BL21 PLysS (DE3) bacteria expressing 
pET28(b)-RIIα(WT) and coupled to SULFO-SBED. Whole cell extract from SKOV-3 
cells plated on 10µg/mL fibronectin was incubated with RIIα-sulfo SBED. Prior to 
incubation with RIIα, lysate is incubated with 50µM Ht31 or Ht31P for 1h. UV-
activatable azide group was crosslinked to putative AKAPs binding to RIIα with UV-
light (365nm). 100mM DTT was used to reduce the disulfide bond, completing the 
transfer from RIIα to its binding partners. Streptavidin beads were used to selectively 
isolate biotinylated proteins. 
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crosslink RIIα to interacting partners, and transfer the biotin affinity tag onto binding 
partners. Selective pulldown of the biotin adduct using streptavidin-beads, allows the 
isolation of binding partners and subsequent identification. This is a powerful in vitro 
method for protein interaction discovery and has been used successful in the 
characterization of novel protein interactions.  
For our application, we wanted to enrich for PKA type II interactions with 
AKAPs, and therefore made use of the ability to purify the PKA RIIα subunit. 
Additionally, we anticipated treatment of lysate with our Ht31 disruptor peptide, would 
result in disrupted PKA-AKAP interactions, preventing the transfer of the biotin 
adduct. Based on the previous data, and the lab’s interest in cell migration, it is 
conceivable to think the PKA activity is spatially regulated through an AKAP 
intimately involved in cytoskeletal dynamics.  
 
3.1.2 Characterization and optimization of the biotin transfer method  
Because of the novelty of the technique, there were a number of optimizations 
and characterizations that were necessary upfront. To determine if the sulfo-SBED 
reagent worked with our application, purified RIIα from BL21, was coupled according 
to the manufacturer’s directions. RIIα coupled and uncoupled to the sulfo-SBED were 
analyzed by SDS-PAGE and blotting for biotin with streptavidin-HRP (Fig. 2A). As 
expected, the uncoupled RIIα showed no presence of biotin, however the coupled RIIα  
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Figure 2: Characterization and Optimization of Biotin Transfer Method 
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Figure 2: Characterization and Optimization of Biotin Transfer Method. (A) 
Purified RIIα either coupled to Sulfo-SBED or not, was analyzed by SDS-PAGE. 
Streptavidin-HRP was used to detect the presence of biotin groups and detection of 
multiple bands shows RIIα is not 100% pure. (B) SKOV-3 cells were plated on 
10µg/mL and lysed in m-RIPA buffer. Biotin transfer method was done in 100µg 
whole cell extract while control lane did not receive RIIα-sulfo SBED. Streptavidin 
pull-down was done and following washes with RIPA buffer, biotinylated proteins 
were eluted and separated by SDS-PAGE. Pull-downs were immunoblotted with α-
mouse AKAP79 antibody and whole cell extract was included for control. (C) Biotin 
transfer method in 100µg whole cell extract from SKOV-3 cells with titrated amounts 
of RIIα (1:100, 1:200, 1:1000, 1:2000 w/w RIIα:extract). A no RIIα control lane was 
used additionally. Streptavidin pull-down was done and following washes with RIPA 
buffer, biotinylated proteins were eluted and separated by SDS-PAGE. Pull-downs 
were immunoblotted with α-mouse AKAP79 antibody and α-mouse tubulin antibody 
and whole cell extract was included as a control. (D) Biotin transfer method in 100µg 
whole cell extract from SKOV-3 cells with titrated amounts of streptavidin beads used 
in pull-down (25µL, 50µL, 100µL). A no RIIα control lane was used additionally. 
Streptavidin pull-down was done and following washes with RIPA buffer, biotinylated 
proteins were eluted and separated by SDS-PAGE. Pull-downs were immunoblotted 
with α-mouse AKAP79 antibody and α-rabbit RIIα (sc-908) antibody and whole cell 
extract was included as a control. 
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had multiple detectable bands, suggesting the coupling of sulfo-SBED to other proteins. 
This suggested that the purity of the RIIα had been compromised. Given the specificity 
of Ht31 for PKA-AKAP interactions, the purity of the RIIα was less concerning 
although still provides substantial evidence for further optimization of the technique.  
To determine if the biotin was successfully being transferred to a known AKAP, 
we searched for the presence of the biotin group on a well characterized AKAP in the 
presence or absence of the RIIα-Sulfo SBED. AKAP79 has been well described as a 
canonical AKAP which binds to PKA RIIα through the conserved amphipathic helix 
(Scott). As expected, the pull down with streptavidin beads revealed the biotin group on 
AKAP79 only when lysate was treated with RIIα-sulfo SBED and not with purified 
uncoupled RIIα (Fig. 2B). This supported the hypothesis that AKAP79 can only be 
pulled down if the RIIα had successfully transferred a biotin group. This provided 
strong evidence of the method working with our target interest group of proteins. 
Additionally, to be sure we were detecting AKAP79 as a function of RIIα and it was 
not alternatively selectively pulled-down by interacting with the beads, we examined 
whether or not we could detect it in the absence of RIIα-sulfo SBED. The absence of 
AKAP79 with no RIIα, suggested that it was in fact selectively pulled-down as a result 
of biotin transfer from RIIα (Fig. 2B).  
The conditions used in previously described experiments were based on initial 
experiments done a number of years prior. As these conditions were not previously 
optimized, there were justifiable grounds to do so. To examine the amount of RIIα 
needed, the ratio of RIIα to lysate (w/w) was titrated. Additionally, there were some 
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initial observations of non-specific proteins present in the pull-downs, suggesting 
possibly the RIIα was in great excess and therefore non-selectively binding and 
transferring biotin to a number of proteins in the cell. In order to reduce the signal to 
noise ratio of specific RIIα binding partners to non-specific partners, RIIα amounts 
were titrated in WCE (Fig. 2C). Pull-downs followed up with immunoblotting of both 
AKAP79 and tubulin, specific and non-specific PKA binding partners respectively, 
were used to assess biotin incorporation. The amount of AKAP79 selectively pulled 
down dropped proportionally as a function of amount of RIIα as expected (Fig. 2C). By 
contrast, no tubulin was detected as a function of streptavidin pull-down, suggesting no 
biotin incorporation onto non-specific proteins. Additional immunoblotting of other 
proteins not expected to bind RIIα, showed similar results as tubulin (data not shown).  
In order to determine the optimal amount of streptavidin-beads to use in the pull 
down, a similar titration was done varying the amounts of the beads relative to the 
lysate. Consistent with previous results, we detected no AKAP79 in the no RIIα control 
lane. Unexpectedly, we did not see an increase in the amount of AKAP79 selectively 
pulled-down as a function of increasing the amount of beads (Fig. 2D).  
  
3.1.3 Ht31 disrupts the AKAP79-PKA interaction in SKOV-3 cells 
The Ht31 peptide has been well characterized as disrupting the PKA-AKAP 
interaction. It has been widely used as a mechanism to study PKA anchoring (Scott et 
al., 2013). Taken from a known AKAP, AKAP-Lbc, Ht31 contains the PKA R subunit-
binding domain, the canonical amphipathic helix. We therefore we sought out to 
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determine whether or not this peptide would disrupt RIIα-sulfo SBED interaction in 
lysates, and thus lead to a decrease in the amount of biotin transferred to known 
AKAPs. Using varying concentrations of Ht31, or the control peptide, Ht31P, we saw a 
decrease in AKAP79 in our pull-downs in the presence of the disruptor peptide, but not 
with the control peptide (Fig. 3A). Quantification of this shows over a two-fold 
reduction is relative amounts of AKAP79 selectively pulled-down using streptavidin 
beads (Fig. 3B). While 50µM showed the most significant decrease in amount of 
AKAP79, there were concerns about the control peptide also disrupting the AKAP-
PKA interaction (Fig. 3A). While non-AKAPs were found in the pull-down, Ht31 did 
not appear to have an effect on the amount of those proteins detected (data not shown). 
These data suggested that Ht31 was in fact specifically disrupting the PKA-AKAP 
interaction.  
 
3.1.4 Interaction between Filamin A and RIIα in SKOV-3 cells 
The search for leading edge AKAPs began a few years ago in our lab, and the 
biotin transfer method had been previously applied to both cell body and pseudopods 
(purified leading edge structures). Mass spectrometry data from the initial experiments 
provided strong evidence for some potential and novel AKAPs that may be responsible 
for the observed PKA activity at the leading edge. From this data set, the protein 
identified with the most significant p-value, was Filamin A (FLNa), an actin-binding 
protein intimately involved in actin cytoskeletal dynamics (Stossel et al., 2001; 
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Nakamura et al., 2007). Showing both a strong reduction as a function of Ht31, and 
strong biological relevance,  
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                    Figure 3: Ht31 but not Ht31P disrupts RIIα-AKAP79 interaction in SKOV-3 cells 
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Figure 3: Ht31 but not Ht31P disrupts RIIα-AKAP79 interaction in SKOV-3 cells. 
(A) Biotin transfer method in 100µg whole cell extract from SKOV-3 cells treated with 
titrated amounts of Ht31 or Ht31P (10µM, 25µM, 50µM) for 1h. Streptavidin pull-
downs were done and following washes with RIPA buffer, biotinylated proteins were 
eluted and separated by SDS-PAGE. Pull-downs were immunoblotted with α-mouse 
AKAP79 antibody and whole cell extract as a control. (B) Relative densitometry is 
depicted in the black bar graph.  
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we attempted to characterize filamin A as a potential AKAP. Given filamin’s role in 
mechanotransduction, myriad of over ninety binding partners, and dynamic regulation 
over cytoskeletal dynamics, this was a very exciting finding.  
Some of the initial sA pull down and co-immunoprecipitation experiments 
showed strong evidence of an interaction between RIIα and FLNa. Even more, an in 
silico approach  identified a region in the N-terminus whose sequence has the potential 
of forming an amphipathic helix (data not shown). This supported our hypothesis that 
FLNa is a cytoskeletal AKAP. Therefore, to carry our investigation further, we sought 
to confirm this interaction using traditional biochemical methods. 
Immunoprecipitations for both RIIα and IgG, as a control, were performed in both 
HEK293 and SKOV-3 cells under varying conditions. Many results showed filamin A 
present only with RIIα and not with IgG (Fig. 4A), supporting our hypothesis and 
further suggesting an interaction between RIIα and FLNa. However, when 
immunoprecipiations were repeated, different results were observed, showing filamin A 
present in both the RIIα and IgG lanes, suggesting filamin A may not be specifically 
interacting with RIIα (Fig. 4B). FLNa binding partners is comprised of 24 
immunoglobulin-like domains, which have been described as inherently sticky, it is 
plausible to believe that the observed interaction between filamin A and RIIα is non-
specific. AKAP79 is as a well described and canonical AKAP, therefore we were able 
to use it as our positive control. Our data showed AKAP79 present only in the presence 
of RIIα and not with IgG, supporting the ability of this technique to confirm AKAPs.       
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Figure 4: Interaction between Filamin A and RIIα in SKOV-3 cells  
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Figure 4: Interaction between Filamin A and RIIα in SKOV-3 cells. (A) 
Untransfected SKOV-3 cells were cultured on 10µg/mL fibronectin and lysed in RIPA 
lysis buffer. 100µg of whole cell extract was treated for immunoprecipipation for PKA 
RIIα or rabbit IgG as a control. Immunoprecipiations were separated by SDS-PAGE 
and immunoblotted with antibodies against filamin A (FlnA), PKA RIIα, and AKAP79 
as indicated. The positions of the molecular weight markers are indicated. (B) 
Immunofluorescence detection of proximity ligation assay signal for filamin A/ RIIα 
interaction in SKOV-3 cells after plating and fixing on 10µg/mL fibronectin. 
Paxillin/FAK and ezrin/ RIIα were used as positive controls and FAK/Lamin A/C 
interaction was used for negative control. Individual events of red PLA signal were 
used as reading output. DAPI was used to stain nuclei (blue). Images were taken at a 
magnification of 20x.   
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Given that the observed results varied substantially and we were unable to 
resolve the inconsistencies in the data, we sought to confirm this interaction using a 
non-traditional approach. Proximity ligation assay was used to analyze the interaction 
between RIIα and FLNa in SKOV-3 cells plated on 10µg/mL fibronectin. The 
interaction between focal adhesion kinase (FAK) and paxillin (pxn) has been 
extensively characterized and served as a positive control (Hildebrand et al., 1993). 
Additionally, we used ezrin and RIIα as a positive control for AKAP-PKA interaction 
as this interaction has been well described (Dransfield et al., 1997). FLNa and RIIα 
showed a distinct pattern similar to what was observed in both positive controls (Fig. 
4C). These data further supported our hypothesis that filamin A and RIIα interact and 
that filamin A may be a potential novel AKAP.  
 
3.1.5 Cytoskeletal fraction from SKOV-3 lysate shows enrichment of cytoskeletal 
proteins  
While the data confirming the RIIα FLNa interaction were inconsistent, the 
RIIα  AKAP79 data were strongly suggestive of the potential of using the biotin 
transfer method as a successful method to identify AKAPs. Although the data was 
inconclusive of filamin A being the potential AKAP responsible for leading edge PKA 
activity, the question remained the same. We therefore sought out to repeat the biotin 
transfer method, with a few modifications. Filamin A was originally found in protein 
extracts isolated from pseudopods. However, pseudopodial preparations suffer from 
several limitations, not at least of which is the recovery of very little protein.  
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We sought out to selectively isolate the cytoskeletal fraction, to enrich for 
potential cytoskeletal AKAPs. Borrowing methods from the literature (Avnur and 
Geiger, 1981; Kuo et al., 2012), we fractionated lysate from SKOV-3 and isolated the 
nuclei away from the cytoplasmic and cytoskeletal contents (Fig. 5A). The isolation of 
focal adhesions has been well described (Kuo et al., 2012), and confirmation of their 
isolation technique was confirmed using western blotting. We therefore chose protein 
targets for immunoblotting, which should remain in distinct subcellular fractions in 
order to confirm our method. Actin remained in the cytoskeletal fraction, after 
cytoplasmic contents were collected; suggesting our cytoskeletal stabilizing buffer (see 
Materials and Methods) was working as expected. While there was still actin remaining 
in the nuclear fraction, this was likely due to the contamination from un-lysed whole 
cells remaining (Fig 5B). Paxillin, a known focal adhesion protein, showed enrichment 
in the cytoskeletal fraction compared to the nuclear fraction (Fig. 5B). Additionally, 
GAPDH, a predominant cytoplasmic protein appeared to be enriched in the cytoplasmic 
contents (Fig. 5B). Lamin A/C was used a marker for the nucleus, and showed 
significant enrichment in the  nuclear fraction, suggesting we were retaining nuclear 
integrity during the cytoskeletal isolation (Fig. 5B). Taken together, these data 
suggested we had a successful method for isolation of the cytoskeletal fraction. This 
method however had little optimization, and further improvement could allow for a  
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Figure 5: Cytoskeletal fraction from SKOV-3 lysate shows enrichment of cytoskeletal proteins  
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Figure 5: Cytoskeletal fraction from SKOV-3 lysate shows enrichment of 
cytoskeletal proteins. (A) Schematic of method used for cell fractionation and 
cytoskeleton isolation. SKOV-3 cells were plated on 10µg/mL fibronectin and let 
adhere for at least 24 h and cells were grown to ~90% confluence prior to lysis. 
Cytoskeletal stabilizing buffer was added to cells to puncture the cell, removing 
cytoplasmic contents. Cytoskeletal fraction is solubilized in RIPA and in-tact nuclei are 
separated from cytoskeletal fraction by centrifugation. (B) 15µg of protein from each 
fraction were separated by SDS-PAGE and immunoblotted with antibodies against 
Lamin A/C, GAPDH, Paxillin, and Actin as indicated.  
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greater isolation of the cytoskeleton from cytoplasmic and nuclear fractions. The 
greatest challenge with this preparation is the amount of protein recovered from in the 
cytoskeletal fraction. Consistently, protein yields were around 40µg from a 10cm dish 
of confluent SKOV-3 cells.   
 
3.1.6  Coomassie staining of streptavidin pull-downs from SKOV-3 lysate submitted for 
mass spectrometry analysis 
Both previous data and initial optimization of the biotin transfer method 
suggested this was in fact a successful technique to identify AKAPs. We therefore 
wanted to first apply this method to whole-cell extracts from SKOV-3. Due to the 
technical difficulties involved with the cytoskeletal fractionation, we wanted to 
establish a working system before proceeding to the application of the biotin transfer in 
the cytoskeletal preparations.  
To be sure that we were non-specifically pulling down proteins independently 
of RIIα, we included a streptavidin (sA) pull down from whole cell extract excluding 
RIIα. Streptavidin pull downs from whole cell extract were done in 150µg of protein in 
the absence and presence of Ht31. While this amount much lower than those typically 
used for mass spec analysis, observation of proteins via coomassie staining and advice 
from the proteomics facility encouraged us to proceed using the pull-downs from 
150µg  (Fig. 6A). Three lanes were cut out of the gel, and subsequently cut into smaller 
slices (see materials and methods). A tryptic digest was done following the instructions 
provided by the proteomics facility and samples were submitted for analysis.  
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Figure 6: Coomassie staining of streptavidin pull-downs from SKOV-3 lysate submitted for 
mass spectrometry analysis 
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Figure 6:  Coomassie staining of streptavidin pull-downs from SKOV-3 lysate 
submitted for mass spectrometry analysis. (A) Whole cell extract from SKOV-3 
cells plated on 10µg /mL fibronectin were lysed in m-RIPA buffer. Streptavidin pull-
downs were performed in 150µg of whole cell lysates treated with RIIα-sulfo SBED for 
45’ followed by treatment with or without 50µM Ht31 disruptor peptide for 1h. A 
streptavidin pull-down in lysates not treated with RIIα was included as a negative 
control. Pull-downs washed in RIPA buffer and eluent was separated by SDS-PAGE. 
Samples were run on 10% gel and stained with coomassie true blue. 10µL of pull-down 
supernatants was separated by SDS-PAGE and run alongside pull-down. (B) 
Cytoskeletal fractions from SKOV-3 cells plated on 10µg/mL fibronectin were isolated 
from cell extracts and pooled together. Streptavidin pull-downs were performed in 
1000µg of cytoskeletal lysates treated with RIIα-sulfo SBED for 45’ followed by 
treatment with or 50µM Ht31 or 50µM Ht31P for 1h. Pull-downs washed in RIPA 
buffer and eluent was separated by SDS-PAGE. Samples were run on 10% gel and 
stained with coomassie true blue. Gels were subsequently sliced, trypsinized, and 
submitted for mass spectrometry analysis.   
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After receiving the data from the facility, we were able to identify AKAP79, as well as 
other known AKAPs (data not shown). Both AKAP79 as well as other known A-kinase 
anchoring proteins, showed a decrease in number of peptides in the presence of Ht31, 
supporting our hypothesis. Furthermore, after examining the dataset more closely, we 
noticed that as expected, Ht31 had no observed effect on another family of proteins, the 
annexins. These observations showed specific disruption of the PKA-AKAP 
interactions. This suggested the method was working within our application, and 
provided evidence to proceed using the cytoskeletal preparations. Concerned about 
missed proteins due to low abundance and to achieve levels of bound proteins sufficient 
for mass spectrometry, we scaled-up the amount of input from 150µg to 1000µg. Based 
on the data from the no RIIα control, we decided to omit this from our second pull 
down in an effort to save materials. Pooling together a number of cytoskeletal 
preparations, we performed streptavidin pull-downs in the presence of either Ht31 or 
the control peptide Ht31P (Fig. 6B). Coomassie staining showed both a decrease in total 
number of bands and intensity of bands observed in the presence of the Ht31 peptide 
compared to the Ht31P control peptide (Fig. 6B). Lanes were sliced and tryptic digests 
were done as previously described for whole cell extract. Based on recommendations 
from the proteomics facility, an additional alkylation and reduction step was done on 
samples from cytoskeletal preparations. Peptides were extracted and subjected to liquid 
chromatography tandem mass spectrometry in a linear ion trap mass spectrometer.   
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3.1.7 List of candidate proteins selected from SKOV-3 cytoskeletal fraction and whole 
cell extract 
Mass spectra were analyzed using SEQUEST and Mascot and a concatenated 
forward and reverse human NCI protein database approach (Elias and Gygi, 2007). Our 
initial data analysis involved filtering of top SEQUEST peptide matches to around 1% 
false discovery rate (described in materials and methods). In our whole cell extract 
database, this method identified 3366 peptides and 3364 peptides in the absence or 
presence of Ht31 respectively (data not shown). In the cytoskeletal fractions, we 
identified 1636 and 1371 peptides in the presence of either Ht31P or Ht31 respectively. 
This provided a very high stringency and confidence for protein identification. These 
experiments were intended to act as a preliminary screen for AKAPs, which subsequent 
biochemical methods would be required for confirmation of any potential hits. With 
this in mind, we therefore decided to lower the stringency of which our proteins were 
identified, to create a more comprehensive list of potential AKAPs. Following the 
“high confidence” analysis, we lowered the cross-correlation scores (x-corr), which 
facilitated SEQUEST peptide matches to >5% false discovery rate (see materials and 
methods) and created a “low confidence” dataset (data not shown). In our whole cell 
extract, this method identified 31273 and 33301 peptides in the absence and presence of 
Ht31 respectively, while in the cytoskeletal fractions the method identified 30653 and 
26915 proteins in the presence of Ht31P or Ht31 respectively. While the strength of the 
mass spectra assignments was compromised slightly, the dataset generated is much 
greater. This allowed us to identify known AKAPs, including AKAP79 which had been 
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previously confirmed by immunoblotting (Fig. 2 and 3). Given the size of these 
datasets, we needed a way to narrow down the proteins and select a list of candidate 
proteins that are potential AKAPs.  
Although Ht31 should ideally greatly disrupt PKA-AKAP interactions, there 
was still evidence of AKAPs by mass spectrometry identification. Using total number 
of peptides identified for a protein as an initial rubric, we sought to determine the 
peptide fold-decrease from Ht31P to Ht31 for each protein (see materials and methods). 
In order to trim the dataset further, the fold decreases or “displacement factor” were 
sub-divided into four categories; x=100 x ≥ 50, 50>x>0, x=0, with x=100 representing 
those proteins found exclusively in the presence of the Ht31P control peptide. 
Simultaneously, proteins were analyzed using PANTHER Gene Ontology and sorted by 
protein class. Comparing proteins with a “displacement factor” between 50 and 100 to 
the gene ontology protein class, a list of candidate proteins was generated subjectively 
(Table 1). While this protein list was chosen relatively arbitrarily, particular attention 
was paid to protein class and included only those proteins labeled by PANTHER as 
“cytoskeletal”, “cell adhesion/cell junction”, or “signaling”. Additional proteins were 
included if they had a significant “displacement factor” and were known to interact 
with cytoskeletal proteins (eg. filamin A-interacting protein 1). The number of peptides 
identified was included in this list to allow for another level of stringency, as proteins 
with 1 or lower peptides identified were removed from the list. The datasets were 
scanned and searched for known A-kinase anchoring proteins. In some cases, the 
identification of these varied between the datasets. This provided internal positive 
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controls for what the data should represent for known AKAPs. A number of proteins 
identified from the “cytoskeletal fraction” were known DNA binding proteins, nuclear 
proteins, and a number of cytoplasmic proteins. The presence of these clearly suggests 
the need for improvement and optimization in the fractionation technique.  
The list of candidate proteins was of particular interest as one of the proteins 
which showed the highest “displacement factor” was in fact filamin A. Additionally, 
there were a number of canonical focal adhesion and cytoskeletal proteins which 
showed both a large number of identified peptides and a large “displacement factor”. 
Of particular interest is talin-1, which was previously identified from the initial screen 
(Howe and Baldor unpublished data) in addition to well characterized cytoskeletal 
AKAPs such as ezrin. To this point, we have established a list of potential AKAPs 
which may be responsible for the spatial regulation of PKA activity during cell 
migration and adhesion. Additionally, these data suggest that we have a method to 
selectively isolate PKA RIIα binding partners from SKOV-3 cells. 
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Table 1: Identification of candidate proteins selected from SKOV-3 cytoskeletal fraction and 
whole cell extract 
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Table 1: Identification of candidate proteins selected from SKOV-3 cytoskeletal 
fraction and whole cell extract. Subjectively selected proteins chosen from complete 
dataset from mass spectra analysis, as described in materials and methods, for both 
whole cell extract and cytoskeletal fraction. Dataset indicates which subsequent table 
protein can be found.  IPI number represents accession numbers from the International 
Protein Index. Displacement factor represents the fold change as a function of Ht31; 
calculated as the difference in number of peptides between Ht31P sample and Ht31 
relative to number of peptides in Ht31P sample as identified by the mass spectrometer. 
Displacement factor was binned according to materials and methods, x≥50 (green), 
50>x>0 (orange), 100 indicates those unique to Ht31P (blue). Mass spec strength 
correlates to the filters and xcorr scores used to filter the protein datasets. PANTHER 
protein class refers to the gene ontology as indicated by the PANTHER database. 
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3.1.8 Development and Rationale of Algorithm  
Based on the criteria included in our selected list, we sought to determine a less 
subjective approach to selectively identify potential AKAPs from our large dataset. We 
therefore generated an algorithm which uses the criteria from table 1, and creates a 
score for each of the potential candidates (Fig. 7). Using the same algorithm, we scored 
known AKAPs to establish a range of numerical values in which we would expect 
potential AKAPs to lie.  
The criteria included in the algorithm are as follows: “displacement factor”, 
biological relevance, mass spec strength, total number of peptides in Ht31P, AKAP 
consensus site, and helical projection of the AKAP consensus site. Of these criteria, 
some are more important and therefore carry more weight in the algorithm. Given that 
the Ht31 peptide should displace all canonical PKA-AKAP interactions, the most 
weight was given to those proteins which showed the greatest decrease in number of 
peptides in the presence or absence of the Ht31 inhibitor peptide. This is referred to as 
the “displacement factor”, which represents the difference in number of peptides found 
from the Ht31P to Ht31 treatments, divided by the total found in the Ht31P treatment, 
and was given the most weight in the algorithm. Biological relevance was determined 
based on PANTHER Gene Ontology information, assigning numeric values to 
candidate proteins found in the following PANTHER protein classes: cytoskeleton, 
signaling, junction, and adhesion. Biological relevance was given the second highest 
priority in the algorithm. Both mass spectrometry strength and total number of peptides 
found in the Ht31P experimental lane were given equal priority. Mass spectrometry  
 99 
               
                                    
                  Figure 7: Development and Rationale of Algorithm to  
  
 100 
 
Figure 7: Development and Rationale of Algorithm. (A) Algorithm used to assign a 
numerical score to candidate AKAPs. Certain criteria given higher weight are indicated 
by the numerical coefficient. (B) List of criteria included in the algorithm. Numerical 
values assigned as indicated. Displacement factor represents the difference in total 
number of peptides found in the Ht31 compared  to Ht31P treatments, divided by the 
total number of peptides found in the Ht31P treatment. Biological relevance was 
determined using the protein classes as assigned by PANTHER Gene Ontology 
database. Mass spectrometry strength either indicated as high or low, was determined 
by x-correlation values and peptide confidence as determined by the Thermo Proteome 
Discoverer software. AKAP consensus site used in search was the following: 
(AVLISE) XX (AVLIF) (AVLI) XX (AVLI) (AVLIF) XX (AVLISE) where X 
represents any amino acid. Predicted helix structure determined using software through 
The University of Virginia.  
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strength was either considered “High” and assigned a numerical value of 2, or “Low” 
and assigned a numerical value of 1. “High” and “Low” refer to the strength of the 
cross-correlation scores and peptide confidence as described previously. Finally, the 
identification of an AKAP consensus site and the likelihood that site forms a canonical 
helix were included in the algorithm. The identification of an AKAP consensus site was 
done using an in-silico approach in conjunction with Benjamin King. The helical wheel 
structure was predicted using a helical wheel projection application found through the 
University of Virginia. Helical wheel structure was assigned a value of 2 for “yes” and 
1 for “no” based on the likelihood the AKAP consensus site would form a helix. AKAP 
consensus site was assigned a numerical value of 3 if a potential site was identified and 
1 if there was no site. A value was still assigned even if no AKAP consensus site was 
identified because of the potential the candidate protein could be a non-canonical 
AKAP, binding PKA through an alternative mechanism.  The following AKAP 
consensus site was used in the search: (AVLISE) XX (AVLIF) (AVLI) XX (AVLI) 
(AVLIF) XX (AVLISE) where X represents any amino acid.    
We applied the algorithm described above and looked at some known A-kinase 
anchoring proteins, some of which are also known to be involved in cytoskeletal and 
adhesion dynamics (Table 2). Gravin, WAVE1, AKAP-Lbc, and ezrin, are known 
cytoskeletal-associated proteins which have also been confirmed as AKAPs. AKAP 5 
(AKAP79) and AKAP11 were used to generate values for other known AKAPs, that 
are not cytoskeletal or adhesion proteins. These gave us a numerical range for where we 
would expect to see other potential cytoskeletal and adhesion associated AKAPs.  
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Table 2: Score for known A-kinase anchoring proteins using the developed 
algorithm. Using the algorithm as described in figure 7, known AKAPs were scored. 
Gravin (AKAP12), ezrin, WAVE1, and AKAP-Lbc (AKAP13) are known cytoskeletal 
and adhesion associated proteins. AKAP 5 (AKAP79) and AKAP11 are other known 
AKAPs which have not been described as involved with cytoskeletal and adhesion 
dynamics.  
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CHAPTER 4: Discussion 
A-kinase anchoring proteins (AKAPs) are scaffolding proteins which contribute 
to cAMP signaling pathways through tethering of the cAMP dependent kinase A 
(PKA). AKAPs target PKA to discrete subcellular compartments, as well as 
simultaneously binding multiple other proteins to create large and integrated signaling 
complexes. In this way, AKAPs tightly coordinate and highly localize PKA with its 
target substrates as well as its effectors, to allow for a tight regulation of PKA-mediated 
signaling events distributed around the cell. AKAPs provide temporal and spatial 
regulation and specificity and therefore are essential to mediating a number of cellular 
effects among many diverse biological processes, one of which is cell migration.  
Cell migration plays a crucial role in many aspects of cellular biology and 
subsequently healthy physiology and misregulation can lead to many diseases, 
including cancer metastasis. Successful cell migration requires the organization and 
coordination of many complex processes the least of which are is integrin activation, 
cytoskeletal rearrangements, and turnover of adhesive structures (Howe, 2011). The 
cell’s migration machinery must therefore be tightly regulated by signaling proteins 
which can efficiently convert upstream stimuli into diverse and multiple downstream 
effects. Additionally, complexity of cell motility requires its regulation be controlled by 
a multi-faceted enzyme which is able to integrate multiple pathways with migration 
dynamics. The role of the cAMP-dependent kinase A is perhaps the best example of 
such a regulator. PKA has been well studied as a regulator of cell migration, exerting 
both positive and negative effects (Howe, 2004), and has a number of substrates 
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involved in cytoskeletal organization, adhesion dynamics, and in general cell migration 
(Howe, 2004). Given the important role of PKA in cell migration, the goal of the 
enclosed work was to identify potential AKAPs which may be responsible for 
regulating the pools of PKA activity involved in cell migration.  
Work in our lab has demonstrated the enrichment of discrete pockets of PKA 
activity in the leading edge of migrating cells (Mckenzie et al., 2011; Howe et al., 
2002) and this activity is both required for migration and focal adhesion dynamics 
(McKenzie unpublished data). This data is corroborated by observations that disrupting 
PKA anchoring inhibits the cell’s ability to form leading edge structures, retain proper 
focal adhesion dynamics, and migrate effectively. These data underscore the 
importance of AKAPs in the processes of cell migration and provide molecular insight 
into important aspects of cell migration. While these and other data established the 
complex, dynamic, and important role for PKA in cell migration, PKA exerts many 
other effects within the cellular context. Therefore, there is a need for localizing and 
specifying PKA activity to sites of cytoskeletal and adhesion dynamics to allow PKA to 
exert its effects on any number of its adhesion and migration-associated substrates 
(Howe, 2004). The goal of this body of work focused on identifying migration and 
adhesion-associated AKAPs. Considering the adhesion and migration machinery 
largely impinges on cytoskeletal dynamics and integrin activation, we chose to enrich 
for the proteins involved in these processes with the hope of identifying potentially 
novel AKAPs.  
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Dissecting the molecular pathway and regulation of PKA activity within the 
leading edge remains to be the focus of our lab, one aspect of which is identifying 
cytoskeletal AKAPs. The question of which AKAPs are responsible for localized 
leading edge PKA activity during cell migration remains to be answered. This body of 
work presents a novel method for the identification of potential AKAPs in vitro. While 
there have been reports of large screens to identify novel AKAPs, this work represents 
the first report of a search for cytoskeletal-specific AKAPs which may be responsible 
for leading edge PKA activity. Furthermore, this study provides sufficient evidence for 
further exploration of cytoskeletal proteins not yet identified as AKAPs, and whose 
contribution to cell migration have yet to be elucidated. Not only did this study propose 
potentially novel AKAPs, but it also provides evidence for further exploration of 
known AKAPs, whose contributions to cell migration have yet to be understood.  
Several AKAPs have been identified as interacting with the cytoskeleton and 
adhesive structures. For example, gravin/AKAP12/SSeCKS, ezrin/radixin/moesin 
family, AKAP-Lbc/AKAP13, and Wiskott-Aldrich syndrome/verpolin protein family 
members 1 and 2 (WAVE1 and 2). These reports however focus mostly on loss-of-
function effects broadly within the cellular context and do not examine the specific 
effects on PKA signaling with respect to cell migration. Indeed, the functional 
consequence of disrupting PKA anchoring and have yet to be elucidated. In fact, these 
studies focus on the phenotypic effect of loss of PKA activity and fail to identify the 
discrete targets which are effected by the loss both PKA anchoring and activity. 
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As part of their role, AKAPs are responsible for assembling and integrating 
large signaling complexes, recruiting multiple binding partners, and anchoring PKA in 
proximity to its targets (Scott et al., 2013). One hypothesis that arises is that PKA could 
regulate migration and adhesion through the direct phosphorylation of key proteins 
involved in these processes, and in fact there have been observations showing direct 
PKA phosphorylation of adhesion and migratory proteins including but not limited to 
VASP, α4 integrin, and filamin A (Dopler and Storz, 2013; Yeo et al., 2011; Howe, 
2004).  However, the effects on these PKA substrates as a result of disrupting the PKA-
AKAP interaction have yet to be identified. These observations would provide an 
important insight into the potential mechanism by which PKA regulates migration 
through anchoring.  
This body of work identified exciting and potential novel cytoskeletal-AKAPs, 
whose role in PKA anchoring and cell migration has yet to be elucidated. Not only can 
AKAPs can contribute to cell processes through anchoring of PKA, but they can 
contribute independent of anchoring function. In fact, a number of proteins with a 
defined cellular role have been subsequently identified as AKAPs (Diviani et al., 2000; 
Klussman et al., 2011; Alto et al., 2002; Lim et al., 2008). This provides evidence that 
a number of AKAPs potentially involved in cell migration have yet to be identified. 
Additionally, this provides ground for further characterizing and delineating their 
contribution to cell migration, defining the potential molecular targets of PKA, and the 
effects on those targets as a result of disrupting PKA anchoring.  
 108 
Much of the work done in examining the role of PKA anchoring with respect to 
cell migration has been done by global inhibition of anchoring, through knockdown or 
knockout models. Therefore making it difficult to delineate the contributions of specific 
AKAPs. A better understanding of these specific contributions could be substantially 
advanced through selective disruption of PKA-anchoring interaction. Deletion mutants 
within the dimerization domain of RIIα, Δ2-5, have been extensively used and well 
characterized (Kinderman et al., 2006).  This study provides an elegant platform for 
further characterization of specific AKAPs and their role in cell migration.  
Considering the differential roles for the previously identified cytoskeletal 
AKAPs, the extensive list of cytoskeletal associated PKA substrates, and the diversity 
of both type I and II PKA anchoring, it is likely that there are multiple AKAPs which 
contribute to the regulation of PKA activity during cell migration. Furthermore, it is 
now clear that multiple AKAPs are even localized to the same subcellular compartment 
(Colledge and Scott, 1999; Edwards and Scott, 1999).  It would be prudent to assume 
that while there is a potential for multiple, yet distinct AKAPs to play a role, there are 
likely significant overlapping targets and functions. Additionally, given the differential 
role of both PKA activation and regulation in cell migration and cell adhesion, it is 
likely that distinct AKAPs are involved in these processes.  
With that in mind, we have identified a number of proteins, which are of 
particular interest and warrant further investigation. Filamin A was identified both in 
this screen as well as in prior investigations. As an actin-crosslinker and 
mechanosensitive protein (Razinia et al., 2012), filamin A is very enticing as a potential 
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AKAP involved in cytoskeletal dynamics and cell migration. While this was a formal 
hypothesis, attempts at characterization of the filamin-RIIα interactions were 
technically challenging. Evidence from both biochemical and in silico data has strongly 
shown the potential of filamin A as an AKAP, with the exciting identification of an 
AKAP-consensus site (Hundsrucker et al., 2010) forming the classic amphipathic helix 
(data not shown). However structure information that was released during the time of 
this investigation showed this sequence to be involved in substantial protein secondary 
structure. More specifically, the potential AKAP sequence is deeply embedded in a β-
barrel of one of the 24 immunoglobulin domains that comprise filamin A, making the 
likelihood of forming the canonical helix strongly unlikely. However, this does not 
exclude the formal possibility of conformational rearrangement of the protein, leading 
to the sequence releasing from its β-barrel and thus forming a helix to facilitate PKA 
binding. Given filamins mechano-properties, a hypothesis that arises from these data is 
that force and tension create strain across filamin A, causing conformational 
rearrangements, and lead to the exposure of cryptic binding sites. Thus as a function of 
tension, there is differential binding of proteins to filamin A (Chen et al., 2009; 
Rognoni et al., 2014; Rognoni et al., 2012). In fact, it was shown through the use of 
some very elegant biophysical techniques that applying mechanical force across filamin 
A can expose the integrin binding site on IgFLNa21 (Ruskamo et al., 2012; Pentikainen 
and Ylanne, 2009). These forces are of physiologically importance since filamin A is 
subjected to forces from the cytoskeletal network of actin filaments, as well as the 
extracellular forces conveyed through integrins.  
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Consistent with the hypothesis that filamin A may be an AKAP, it is plausible 
to assume that PKA binding could be regulated through a similar mechanism. This 
would provide a beautiful integration of tension to PKA-mediated signaling events and 
one, which is tightly controlled. Given the lab’s focus on mechanotransduction of PKA 
activity at the leading edge of migrating cells, filamin A would be an ideal candidate 
for contributing in this process.  
Although identifying filamin A as a mechanosensitive AKAP involved in cell 
migration would contribute significantly to the fields of cell migration and 
mechanobiology, there are other potential proteins which are of similar excitement. 
Using a largely subjective approach to screen the mass spectrometry data, this study 
identified a number of proteins of biological relevance and showed disruption with the 
Ht31 peptide. While this is a good starting point for further investigations, it is not 
unlikely that a number of proteins were missed using this screen. There have been 
reports of “noncanonical AKAPs” including pericentrin and α4 integrin whose RIIBD 
is distinct from the amphipathic helix highly conserved across known AKAPs (Diviani 
et al., 2000; Lim et al., 2008). Furthermore, these reports have shown that 50uM Ht31 
does not disrupt the PKA-AKAP interaction, which provides evidence that our screen 
could be missing other such noncanonical AKAPs. Additionally, our lab has shown that 
PKA activity is localized to the leading edge of neuronal cells, a pool of which is 
resistant to disruption suggesting further evidence of PKA localization through 
noncanonical AKAP mechanisms (Rivard et al., 2009).  
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Given the large and likely possibility of both false positives and false negatives 
resulting in potentially missed proteins, there is obvious need for improvement and 
optimization of this method. The biotin transfer method was intended as a preliminary 
screen, the list of identified proteins was not to be directly published, but instead 
provided primary evidence to warrant further biochemical methods for confirmation. 
Therefore although there was some optimization prior to the pull-downs, errors in 
experimental design could be tolerated due to the more stringent nature of the analysis 
with the dataset. For example, the observed contaminations in our purified RIIα sample 
were likely subjected to the same coupling to sulfo-SBED, allowing proteins other than 
RIIα to be capable of biotin transfer. However, the specificity of Ht31 for PKA-RIIα 
interactions provides an intrinsic way of distinguishing canonical AKAPs from other 
non-specific proteins containing a biotin group transferred from either RIIα or other 
contaminants. 
 The list of candidate proteins contained in this thesis was as previously 
mentioned, subjectively chosen. The extensive list of proteins identified by mass 
spectrometry provides evidence for further optimization. The PANTHER gene 
ontology database provides an excellent way to group proteins by class, and should be 
expanded upon further as a way of eliminating proteins. An algorithm was developed 
(Fig. 7) as a way of objectively screening the list of hits for potential candidates. This 
takes into account the criteria that were used in the subjective screen, and by adding a 
numerical coefficient, we were able to weight different criteria more heavily than 
others. While this is a general first attempt at an algorithm, a better algorithm will need 
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to be developed. Each of the proteins were scanned to determine if any contained the 
canonical AKAP consensus site. While the presence of a site is included in our 
algorithm this does not exclude the fact that there may be others AKAPs which bind 
PKA through an alternative and non-canonical method of binding, which has been seen 
for other proteins (Howe, Waterman). Using this alogorithm and applying it to known 
AKAPs, we have generated a numerical range of scores which we can use to compare 
to those scores generated from the list of potential candidate proteins.   
Within the list, talin-1 stood out as potentially interesting not only because it 
had a substantial effect from the Ht31, but also because it was previously identified in 
the original dataset. An in silico search for the AKAP consensus site 
(AVLISE)XX(AVLIF)(AVLI)XX(AVLI)(AVLIF)XX(AVLISE) indicated a possible 
site in the c-terminus, which also showed the formation of an amphipathic helix. Talin 
is of particular interest because of its involvement in integrin activation and its role as a 
scaffolding protein in focal adhesions, providing a link from integrins to the actin 
cytoskeleton (Kanchanawong et al., 2010). Talin-1 was also found in a recent screen 
for AKAPs (Hundsrucker et al., 2010). Taken together, this provides substantial 
evidence to characterize the interaction with RIIα using traditional biochemical 
methods. A number of cytoskeletal and adhesion-associated proteins were identified as 
having a substantial effect from the Ht31, providing good support of our hypothesis.  
Not only did we create a list of potentially uncharacterized and novel AKAPs, 
other known AKAPs were identified. There is merit in their identification beyond 
acting solely as a positive control. The role of AKAPs in cell migration has been only 
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conceptually linked yet the contributions and regulations from specific AKAPs on cell 
migration is not yet understood. Therefore, their identification within our mass 
spectrometry data provides evidence for further elucidating their role in cell migration. 
Ezrin and moesin, members of the ERM family, have been implicated as cytoskeletal-
associated proteins however their role in cell migration has only begun to be explored. 
The mechanisms by which ezrin affect migration and adhesion still remains unclear. 
Additionally, gravin (AKAP12) has only minimally been described with respect to cell 
migration (Akakaura and Gelman, 2012). Gravin has been shown to play diverse 
functions from cytoskeletal rearrangements (Gelman, 2010) to direct involvement with 
the beta2 adrenergic receptor  however whether or not these functions are regulated by 
PKA has yet to be described. 
Of the known cytoskeletal AKAPs, AKAP-Lbc (AKAP13) has perhaps been 
best understood with respect to cell migration. Recently, AKAP-Lbc was found to be 
responsible for playing a substantial role in formation of PKA activity gradients 
(O’Connor et al., 2012). Additionally, AKAP-Lbc was identified as a RhoA regulator, 
specifically as a guanine nucleotide exchange factor (Diviani et al., 2006). While these 
observations begin to delineate the role of AKAP-Lbc in migration, they focus on this 
role with respect to the guanine exchange factor function of AKAP-Lbc instead of its 
function as a PKA anchoring protein. WAVE1 was one of the first cytoskeletal 
associated AKAPs and functions as a scaffolding protein to couple Rho GTPases to the 
Arp2/3 complex, regulating actin polymerization (Diviani et al., 2006). WAVE1 has 
been found to play a critical role in cell migration through actin reorganization. 
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However, similar to ezrin and gravin, the contribution to cell migration through PKA 
anchoring has yet to be defined. Taken together, this establishes the need to define 
cytoskeletal AKAPs responsible for regulating PKA activity and contributing to cell 
migration. 
While this study was successful in identifying potential cytoskeletal AKAPs, 
there are a number of experiments needed to confirm and characterize any of the 
candidates as a bonafide AKAP. As mentioned earlier, there are in silico approaches 
that although they have their limitations, can provide both a quick and inexpensive way 
to search for AKAP consensus sites. Traditional biochemical approaches should be 
taken which can serve to confirm the binding to RIIα. Co-immunopreicipatations, when 
including the proper controls, can be powerful mechanisms to assess binding. Not only 
can Ht31 and Ht31P be used within this context, but evoking the use of the RII deletion 
mutant (Δ2-5) and other deletion mutants, can help to characterize interactions while 
mapping particular regions of binding. In vitro binding experiments can allow for the 
confirmation of protein-protein interactions, eliminating any problematic experimental 
conditions, and further elucidating whether or not the interaction is direct or indirect. 
Given the integrity and accessibility of purified proteins, these are relatively 
inexpensive.  
Beyond confirming the interaction, there are a number of additional experiments 
that would be provide functional significance to any potential candidate. Given the labs 
interest in PKA’s role in regulating cell migration and adhesion dynamics, another facet 
to identifying new cytoskeletal AKAPs is to identify the discrete targets of PKA whose 
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phosphorylation is regulated through AKAP binding. Identifying these PKA substrates 
can be done through a number of biochemical approaches such as performing 
phosphoproteomics on samples treated with PKA inhibitors and effectors as well as 
general immunofluorescence. Cytoskeletal and focal adhesion proteins can be enriched 
using similar methods as presented in this text. Mutagenesis studies could be used to 
follow up potential candidates to confirm the precise role of PKA phosphorylation. 
Considering the canonical role AKAPs play in targeting PKA and organizing signaling 
complexes, determining the discrete PKA targets effected by disruption of PKA 
anchoring would be provide important insight into the molecular mechanisms of PKA-
mediated cell migration.  
After potential cytoskeletal or adhesion-associated AKAPs are identified, and 
characterized, further experiments would be required to determine a functional role in 
cell migration. A number of approaches could be taken at this juncture. Given the lab’s 
expertise with the FRET-based PKA activity reporter, the contribution of identified 
AKAPs within our cell migration model could be examined in this context. Deletion 
mutants in candidate proteins would be particularly interesting, given they would 
provide insight into the effects of specifically disrupting PKA anchoring compared to 
broad scale anchoring disruptors (Ht31, sAKAP-is, RIAD). Migration assays, such as 
the lab’s well used ‘donut’ assay and wound healing assays would be additional studies 
to examine the specific role in cell migration.  
A parallel project in the lab in collaboration with Neil Sarkar, Ph.D., is looking 
at identifying potential PKA phosphorylation sites in adhesion and integrin associated 
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proteins, using an in-silico approach. This approach may provide evidence of groups of 
proteins which contain a PKA phosphorylation site, clustered around a single protein, 
either through direct or indirect binding. Given that many known AKAPs are 
scaffolding proteins, we hope to combine the data generated with Neil, with our 
candidate protein list and look for any proteins which overlap. Any protein from our 
candidate list which also interacts with a number of proteins containing PKA 
phosphorylation sites, provides strong evidence as a potential AKAP. A preliminary 
screen using Talin-1, identified a number of interacting partners which also contain a 
known PKA phosphorylation site. This provides strong evidence that talin-1 may in fact 
be the AKAP responsible for anchoring PKA and placing it within close proximity to 
its target substrates.  
We and others have shown the critical role for PKA in cell migration and 
adhesion. Our laboratory has additionally established the importance of PKA anchoring 
for migration however; the specific AKAPs responsible have yet to be identified. 
AKAPs, as scaffolding proteins, are able to bind both kinases and phosphatases, and an 
interesting hypothesis is that AKAPs may function as central regulators of the activity 
of signaling complexes in space and time. Specifically, this dual binding ability could 
enable AKAPs to regulate the phosphorylation of PKA substrates, providing transient 
pockets of PKA activity. Identifying the specific cytoskeletal AKAPs involved in 
leading edge PKA activity, associated PKA substrates, and the functional consequences 
of disrupting PKA-AKAP interactions is essential to understanding the role of PKA in 
cell migration and is an ongoing investigation. Given that misregulation of cell 
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migration often leads to cancer and cancer metastasis, understanding the contributions 
of the PKA-AKAP interaction can provide insight into a potentially interesting 
mechanism for the development of targeted therapeutics.   
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